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1CHAPTER I
INTRODUCTION
Autism is a devastating neurological disorder that was first described 
approximately 60 years ago by Leo Kanner. At approximately the same time a German 
scientist, Hans Asperger, described a milder form of the disorder that became known as 
Asperger’s Syndrome. Our understanding of these two disorders have evolved over the 
years and are today listed in the Diagnostic and Statistical Manual of Mental Disorders
DSM-IV-TR (fourth edition, text revision) as two of the five pervasive developmental 
disorders (PDD), more often referred to today as autism spectrum disorders (ASD). 
Pervasive developmental disorders impact a wide range of adaptive attributes. All these 
disorders are characterized by varying degrees of impairment in communication skills, 
social interactions, and restricted, repetitive and stereotyped patterns of behavior. The 
pervasive developmental disorders, or autism spectrum disorders, range from the more 
severe form, called autistic disorder, to a milder (and sometimes more functionally 
adaptive) form, Asperger’s syndrome. Autism and Asperger's syndrome seem to 
represent extreme points on a scale of severity within the autistic spectrum. Those with 
Asperger’s are perceived to be similar to, but more capable than individuals with classical 
autism. In individuals with Asperger's Syndrome, deficits in social interaction and 
unusual responses to the environment, similar to those in autism, are observed. Unlike 
autism, however, cognitive and language development are more likely to fall within the 
2average range in the first years of life, and verbal skills are usually an area of relative 
strength. Idiosyncratic interests are also common and may be displayed as unusual and/or 
limited interest (e.g., memorizing bus/train schedules, preoccupation with facts related to 
a specific subject or class of objects). If an individual exhibits symptoms of either of 
these disorders, but does not meet the specified criteria for either, they are typically 
diagnosed with pervasive developmental disorder not otherwise specified (PDD-NOS). 
Additional severe disorders that are included within the autism spectrum disorders but 
will not be discussed in this paper are Rett’s syndrome and childhood disintegrative 
disorder. 
As noted above, autism and Asperger’s appear to be extreme points on a 
continuum of severity. “The findings from research and clinical work are best explained 
on the hypothesis of a continuum of impairments of the development of social 
interaction, communication and imagination and consequent rigid, repetitive behavior” 
(Wing, 1991, p. 111). Kanner (1973) stated that it was not uncommon for any illness to 
present in different degrees of severity and that it was possible this variation existed 
within autism. The continuum for these disorders ranges from individuals with the most 
profound mental and physical impairments, who have significant social and language 
impairments, to the most capable and highly intelligent individual with a subtle form of 
social impairment. Perhaps Wing (1991) explained it best:
It is necessary to emphasise (sic) that this triad of social impairments, thought of
primary importance, is not the only variable involved in the clinical pictures. 
Language, non-verbal communication, reading, writing, calculation, visuo-spatial 
skills, gross and fine motor co-ordination and all other aspects of psychological 
3and physical function may be intact or may be delayed or abnormal to any degree 
of severity in socially impaired people. Any combination of skills and disabilities 
may be found and any level of overall intelligence. The overt clinical picture 
depends upon the pattern seen in each individual. (p. 111)
Research has established that ASD has a genetic base, however, exposure to 
particular stimuli during pre and post natal periods of development have also been 
suspected in attributing to the cause and differences in severity among individuals. While 
the symptoms associated with ASD often occur with varied intensity it is not completely 
understood what variables are related to these variations among individuals. Rimland 
(1964) noted, it was of interest that in several cases of identical twins stricken with 
autism, the degree of affliction was not identical, suggesting that while genetic factors 
may predispose toward autism, post-conceptional factors could also be operative. 
Research is somewhat inconsistent due to the varied methodologies in defining and 
assessing severity as well as varied classification criteria used over the decades (Glasson, 
Bower, Petterson et al., 2004). Severity has not been well defined within the literature as 
definitions of severity varied widely among researchers.  Defining severity, as it pertains 
to ASD, can include assessment of adaptive behavioral functioning, standard scores from 
cognitive and/or diagnostic rating scales, or by the number of symptoms exhibited. For 
the purpose of this study, severity was defined by standard scores on adaptive functioning 
and specific diagnostic rating scales. 
Most children with ASD have some degree of impairment in adaptive functioning 
(Liss et al., 2001). Information related to adaptive functioning and symptomology along 
with other prognostic data can be helpful in determining the severity of the disorder. But 
4minimal research has been conducted on which variables correlate specifically with 
adaptive functioning and diagnostic criteria in predicting the severity of ASD. 
Because all the PDD disorders are characterized by varying degrees of the same 
symptomology there is confusion and continuous debate as to whether Asperger’s is a 
separate disorder than autism (Cohen & Volkmar, 1997; Woodbury-Smith, Klin, & 
Volkmar, 2005; Wing, 2005). Review of the literature indicated that most researchers 
view the disorders as synonymous and therefore discuss them collectively under terms 
such as autism, autistic disorders, autism spectrum disorders, and/or pervasive 
developmental disorders. Asperger’s syndrome wasn’t truly recognized in the United 
States until 1991 when Hans Asperger’s original paper was translated into English 
(Wing, 2005). Prior to that its only introduction was noted by a large scale review of 
literature and case studies published by Wing in 1981. Additional recognition for 
Asperger disorder followed its inclusion in the International Classification of Diseases, 
Tenth Edition (World Health Organization, 1993) and Diagnostic and Statistical Manual 
of Mental Disorders, Fourth Edition (American Psychiatric Association, 1994). And 
although the condition has received increased attention during the last two decades, data 
are still sparse in comparison to autism (Wing, 2005). A lack of definitive data limits
information regarding the prevalence of Asperger’s (APA, 2000), however it appears to 
be lower than autism (Fombonne, 2001). Furthermore, due to the lack of recognition 
within the United States until the 1980’s, because the two have not been definitively 
distinguished as separate disorders, and because the prevalence of Asperger’s is estimated 
to be lower (Fombonne, 2001), the two conditions are often accounted for under the term 
autism or autism spectrum disorders. Because of these circumstances, those who 
5pioneered research on Asperger’s were unlikely to obtain enough participants for 
adequate analysis of these individuals independently. Therefore this paper more 
frequently uses the term autism as that is how the spectrum was commonly portrayed 
throughout the literature. However, when applicable, separation of these disorders was 
noted.
Autism spectrum disorder is often mistakenly referred to as a rare disorder, but 
advances in understanding of this disorder have shown that it is more common than
previously believed. The diagnosis of autistic disorders may have increased by 273% 
between 1987 and 1988 and by 97% between 1998 and 2002. (California Department of 
Developmental Services, 2003 as cited in Purssell, 2004). The incidence of autistic 
disorders in most studies conducted 15 to 20 years ago estimated the frequency of autism 
to be 4-5 per 10,000 ( Bohman, Bohman, & Bjork, 1983; Gillberg, 1984, 1988; 
McCarthy, Fitzgerald, & Smith, 1984; Steinhausen, Gobel, & Breinlinger, 1984; Tanioue, 
Oda, Asano et al., 1988; Trevarthen, Aitken, Papoudi et al., 1996; Volkmar, Klin, & 
Cohen, 1997) while recent sources indicate a higher incidence and estimate the frequency 
of ASD to be from 10 to 60 per 10,000 (Baird, Charman, Baron-Cohen et al., 2000; 
Bertrand, Mars, Boyle et al., 2001; Chakarabarti & Fombonne, 2001; Horton, 2004; 
Medical Research Council, 2001 as cited in Purssell, 2004; Yeargin-Allsopp, 2003).  The 
prevalence for Asperger’s syndrome has been estimated to range from .3 to 48.4 per 
10,000 (Baird et al., 2000; Chakarabarti & Fombonne, 2003; Kadesjo, Gollberg, & 
Hagberg, 1999; Sponheim & Skjeidal, 1998; Taylor, Miller, Farrington et al., 1999). This 
enormous variation likely reflects the differences in methodologies across the research. 
However, a review of literature by Fombonne (2001) indicated the rate of Asperger 
6disorder was consistently lower than that of autistic disorder and that the number of 
children with autism was on average five times higher, suggesting the prevalence of 
Asperger disorder to be approximately 2 per 10,000. Despite the difference in prevalence, 
both disorders are found to occur more often in males than females (APA, 2000).
There is no single etiology for autism spectrum disorders, but there are several 
theories which have generated research over the past 60 years. There is evidence for a 
neurological and genetic basis of autism. There is also evidence that a genetic link to 
ASD may be a result of a weakened immune system. Although there is likely a 
significant genetic component, genetics do not appear to account for all cases. This is 
illustrated by the increasing number of children being diagnosed each year. As Horton 
(2004) noted, this raises the possibility that there might be psychological and organic 
factors contributing to autism’s cause and course. Additionally, there is a growing 
concern that viruses associated with thimerosal-containing vaccinations/immunizations, 
particularly the Measles Mumps Rubella (MMR) vaccine, have a role in causing autistic 
disorders. Furthermore an increase in autistic disorders was noted after the introduction 
of the multi-component MMR vaccine. The combined MMR vaccine was licensed for 
use in the United States (US) in 1971 (Kennedy, Byers, & Marchalonis, 2004) and within 
the United Kingdom (UK) in 1988 (Shattock & Savery, 1997). As noted by Geier and 
Geier (2003), the Vaccine Adverse Events Reporting System (VEARS) database 
indicated an increase in the prevalence of autism and other neurodevelopmental disorders 
after the introduction of thimerosal-containing vaccines. Shattock and Savery (1997) also 
noted an increase in the number of concerns reported following the introduction of the 
multi-component MMR vaccine.  
7Although rare, side effects are reported to occur with some vaccines. Examples 
noted by Hsu (1999) included a concern over the rotavirus causing a rare and dangerous 
bowel disorder, seizures as a result of a new strain of the Pertussis vaccine and the 
chicken pox vaccine, as well as paralization from polio vaccines. In fact, in 1986 the 
Vaccine Adverse Effect Reporting System (VAERS) was established for parents and/or 
doctors to report vaccine related injuries and side effects. It is further noted by Hsu 
(1999) that the VAERS receives approximately 1000 reports per month from parents and 
doctors. Review of information published online by VAERS indicates that during the 
years 2000 and 2005, between thirteen thousand and sixteen thousand reports were 
received per year (http://vaers.hhs.gov/info.htm). Therefore the notion that a vaccine 
could play a role in the cause of autistic disorders need not be readily dismissed without 
proper investigation.  
One of the questions raised in early literature from the 1960’s about autism was 
the possibility of an infectious etiology to the syndrome (Chess, 1971, 1977; Chess, Korn 
& Fernandez, 1971; Crook, 1983; Desmond, Wilson, & Melnick et al., 1967; Dykens & 
Volkmar, 1997; Freedman, Fox-Kolenda, & Brown, 1970; Gillberg, 1985, 1986; 
Knobloch & Passamanick 1975; 1970; Rutter, 1977). Although this notion has advanced, 
concerns remain that a child’s weakened immune systems and susceptibility to 
psychological illness may contribute to the disorder. These early studies portrayed 
concerns regarding pre- and post-natal infectious diseases and the impact on children’s 
immune systems as a result of these infections. Studies were conducted that investigated 
whether children who experienced pre- or post- natal infections and/or a suppressed 
immune system developed autistic disorders (Chess, 1971, 1977; Chess, Korn, &
8Fernandez, 1971; Coleman & Gillberg, 1985; Dykens & Volkmar, 1997; Knobloch & 
Passamanick, 1975; Kennedy et al, 2004; Krause, He, Gershwin et al, 2002; Ritvo & 
Ritvo, 1982; Stubbs & Magenis, 1980). It has been noted that a small but significant 
proportion of children develop autism as a result of pre-or post-natal infections; for 
example with rubella, cytomegalovirus, herpes, and others (Gillberg & Coleman, 1992). 
Although the occurrence was rare, Rutter, Bailey, Simonoff et al., (1997) noted cases of 
autism associated with postnatal encephalitis, while both Delong et al. (1981) and 
Gillberg (1986) reported on a case of autism associated with herpes encephalitis.
Knobloch and  Passamanick (1975) reported on cases associated with meningitis, 
varicella, and syphilis. Although only based on anecdotal evidence, it was suggested by 
Crook (1983) and Campbell (1983) that autism was associated with a condition known as 
candida albicans; a sign of impaired immune functioning resulting from the overgrowth 
of yeast in the body. Later studies also assessed risk factors related to utero exposure with 
the use of birth-defect causing substances such as ethanol, valproic acid and prescriptive 
drugs (Rodier, 2000). Although the evidence somehow escaped the attention of earlier 
researchers, evidence linking the use of thalidomide, a morning-sickness drug used in the 
1960’s, with some cases of autism was discovered by Stromland, Nordin, Miller et al., 
(1994). 
Dykens and Volkmar (1997) noted that “interest in the immune system and autism 
arises from the various case reports in which infections (and possibly altered immune 
response) are associated with the development of autism or autistic features” (p. 398). 
Significant research regarding pre- and post-natal infection and autism was particularly 
sparked by the Rubella epidemic that occurred in 1964 (Chess 1971, 1977; Chess et al. 
91971; Coleman & Gillberg, 1985). It was estimated that approximately 20,000 children 
born within the United States alone were negatively affected by the rubella epidemic 
(Coleman & Gillberg, 1985). Studies found that mothers who contracted measles during 
pregnancy were more likely to have a child who developed autism (Chess 1971, 1977; 
Chess et al., 1971). In a study conducted by Chess (1971) it was found that out of 243 
children studied (with congenital rubella) they identified 10 as having autism and eight 
more who had a “partial syndrome of autism” (p. 35). However, the significance of this 
finding was modified by follow-up data, collected by Chess et al. (1977), indicating that 
these identified children, as they grew older, ceased to exhibit autistic symptoms. 
Even in the early literature, a small amount of evidence suggested that infectious 
agents in the post-natal period may have been a factor in the development of autistic 
syndromes. Although the suggestion that autistic disorders could be caused by 
vaccination has been in circulation for many years, the interest appears to have once 
again moved to the forefront of research; however, the studies that have been conducted 
have yielded inconsistent findings (Bernard, Enayati, Redwood et al., 2001; Bernard, 
Enayati, Roger et al., 2002; Coleman & Gillberg, 1985; Kennedy et al., 2004; Krause et 
al., 2002; Shattock & Savery, 1997).
There appears to be little middle ground on this issue, researchers and/or 
clinicians seem to adhere to either a fanatical anti-vaccine position or dismiss any 
possibility that a problem could exist at all in relation to vaccines causing ASD. 
Wakefield has been a primary investigator in researching the link between autistic 
disorders and vaccination; and at times appears to be alone in his support for evidence of 
a link between vaccines and ASD. Singh (2000) is also convinced of a possible link 
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between vaccines, particularly the MMR vaccine and autistic disorders. During a 
committee government reform meeting in April of 2000, Singh related additional 
evidence in support of a link between the MMR vaccine and autism. Singh (2000) spoke 
of research related to autoimmunity and its explanation for a link between vaccines and 
autism and other autoimmune diseases. Bernard et al. (2001) has even equated the onset 
of autism with symptoms readily seen in cases of mercury poisoning, indicating autism to 
be a novel form of mercury poisoning. Research conducted by Geier and Geier (2003, 
2004, 2005) also suggest an association between the onset of autism and other 
neurodevelopmental disorders following immunization, particularly with the use of 
vaccines containing the preservative thimerosal. In addition, Krause et al. (2002) reported 
that “because immune system abnormalities similar to those induced by mercury in 
experimental animals have also been observed in autistic children, a link between 
vaccination with thimerosal- containing vaccines and autism has been suggested” (p. 341).  
It was even suggested as early as 1967 by O’Gorman that autism was possibly the 
consequence of an individual’s inability to metabolize lead.     
There is an increasing amount of research presently being conducted into the 
possible link between autistic syndromes and vaccinations. This increase in current 
research has resulted from the elevated incidence of parents claiming that their child’s 
autism was the result of, or compounded by, vaccination. These parents often describe 
distressing accounts of extremely rapid regression, from perfectly average developing 
children to children who begin to exhibit severe behavioral and physiological problems. 
Clinicians, researchers, and parents alike would agree that by the very definition of 
autism, a period of regression often accompanies the onset of autism, but the timing of 
11
vaccinations with autism, by some is simply interpreted as mere coincidence. Lingam et 
al. (2003) reported that parents, who had observed regression of skills in their autistic 
child rather than delayed development, were more likely to speculate about the MMR 
vaccine and other possible causes of ASD.
There is little doubt that these parents are convinced that their children changed 
dramatically and quickly after an immunization program had been implemented. To 
completely ignore such reported cases, without investigating circumstances, is 
irresponsible, promotes fears and concern among the general public, and does nothing to 
combat these fears. Suspicions about the role of vaccines in the cause of ASD exist and 
data would suggest that these suspicions should be considered for investigation.
If those who proclaim the existence of a link between ASD and certain 
vaccinations are correct, then the consequences could be quite serious for many people.  
On the other hand, if they are incorrect then the message is that vaccines are safe and 
effective. Yet public confidence has been unnecessarily harmed and the control of 
potentially lethal diseases is at risk of being jeopardized by the attitude of uncertainty 
about vaccination.
The very nature of a vaccine is intended to help ones body establish immunity to a 
specified disease by creating antibodies. So how is it that a vaccine can cause an illness 
that is unrelated to the actual disease for which it is created? Those who protest the safety 
of vaccinations claim that the danger is related to a particular ingredient that is contained 
within these vaccines. The ingredient thimerosal, used as a preservative since the 1930’s 
is present in some vaccines and considered harmful by some individuals (Bernard et al., 
2001; Geier & Geier, 2003, 2004, 2005; Shattock & Savery, 1997). The concern over 
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thimerosal is the fact that it contains 49% mercury. Exposure to mercury can have 
potentially significant health effects. Although the level of mercury within any individual 
vaccine is not harmful, the additive amount of mercury that is contained in the usual 
dosage of vaccines given during one visit could allow an excessive amount of mercury, 
which exceeds government-recommended levels, to be ingested (Bernard et al., 2001, 
2002; Freed, Andreae, Cowan et al., 2002; Geier & Geier, 2003, 2004, 2005; Parker, 
Schwartz, Todd et al., 2004). As noted by Freed et al. (2002) the exposure during the first 
six months of a child’s life, assuming they received all recommended vaccine doses was 
as much as 187.5µg of mercury. Research conducted by Geier and Geier (2005), Parker et 
al. (2004), and Redwood, Bernard, and Brown (2001) further noted that the levels of 
mercury children are exposed to not only exceed the Federal Safety Guidelines but that it 
also exceeds the United States Environmental Protection Agency’s permissible hair 
mercury limit. Researchers have shown that exposure to low doses of methyl mercury 
during the prenatal period as well as critical stages of postnatal development was 
associated with minor neurodevelopmental abnormalities(Cox, Clarkson, Marsh et al.,
1989; Marsh, Clarkson, Myers et al.,1987; Redwood et al., 2001). It is clear that children 
are given an aggressive dosage of vaccines throughout their first year of life. While some 
proclaim that the amount of mercury that a child is exposed to within the first year of life 
through these vaccinations exceeds a safe level; government agencies insist that these 
levels are safe over the extended period of time in which these immunizations are 
administered.
The reaction of new parents to the schedules of vaccinations received during the 
first year of a child’s life is likely one of shock. Vaccination schedules for infants do 
13
differ in various parts of the world; however, Shattock and Savery (1997) indicated that 
“schedules used in the United States of America are amongst the most aggressive” (¶8).  
A comparison of immunization schedules in the United States and the United Kingdom 
are shown in Table 1. For the most part immunization schedules are fairly consistent, 
with the exception of influenza added to the immunization dosage during the first year.   
The age of 12 to 15 months is a time in which much difference is noted; children in the 
U.S. appear to be given more immunizations during this time period than children in the 
U.K.
14
Table 1  Comparison of Immunization Schedules
Age Received United States United Kingdom
2 months Diphtheria Diphtheria
Tetanus Tetanus
Pertussis Whooping Cough (pertussis)
Hepatitis B Hepatitis B
Polio Polio
                                                Influenza
3 months Diphtheria
Tetanus
Whooping Cough
Hepatitis B
Polio
4 months Diphtheria Diphtheria
Tetanus Tetanus
Pertussis Whooping Cough
Hepatitis B Hepatitis B
Polio Polio
Influenza
6 months Diphtheria
Tetanus
Pertussis
Influenza
12 to 15 months MMR MMR
Hepatitis B
Vericella
Polio
Diphtheria
Tetanus
Pertussis
4-6 years Diphtheria Diphtheria
Tetanus Tetanus
Pertussis Whooping Cough
Polio Polio
MMR MMR
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Those who adhere to the vaccine-autism link further indicate that a child with a 
weakened immune system is at greater risk for developing autism than the average child, 
and that they are more susceptible to the harsh side effects that can occur with the 
administration of these vaccinations. The effects of such an intense battery of 
vaccinations in such a short period of time could be serious.                                                                                                    
Thus in the first year of life, the immune system of an infant, as well as the infant 
itself, is challenged by injections, directly into its body, of at least 10 diseases.  
Many of these are derived from attenuated strains of living bacteria or viruses. 
An infant with an underdeveloped immune system or one which is already
challenged or compromised for any reason must be vulnerable when such a
battery of vaccinations are used in such a short period of time (Shattock &
Savery, 1997, ¶8). 
Vaccinations have also been speculated to be linked to the cause of ASD after a 
dramatic increase in the number of children identified was seen in relation to the 
introduction of the multi-component MMR vaccine (Bernard, 2000; Shattock & Savery, 
1997; Taylor et al., 1999). The number of different vaccines contained within a single 
injection is referred to as the valency. MMR is therefore a tri-valent vaccine because it 
contains measles, mumps, and rubella vaccines. There has been controversy about the 
immune systems ability to handle a polyvalent vaccine, in that it may in some way 
overload the immune system. 
There is little evidence, even anecdotal evidence, that the older, single component 
vaccines, could result in such problems as autism. Reports of such problems 
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appear after the introduction of the multi-component MMR vaccine. If these 
reports are correct it would seem that it is the combination which is responsible 
for these problems. Given the fact that the Measles virus is known to be 
immunosuppressant, its inclusion in combination with other disease causing 
organisms is, in any case, inherently problematic (Shattock & Savery, 1997, ¶15). 
As a result of the controversy, the Food and Drug Administration (FDA) reviewed 
thimerosal-containing products. In 1999, the FDA discovered that “children could be 
exposed to an amount of mercury from vaccines that exceeded 1 of 3 existing federal 
safety thresholds” (Freed et al., 2002, p. 1153). In response to the findings related to 
safety guidelines being exceeded, the FDA requested that the vaccine manufacturers 
eliminate thimerosal wherever it was deemed possible. Although excessive amounts of 
thimerosal as a preservative are no longer present in most recommended vaccines in the 
United States, for children younger than 7 (Parker et al., 2004), thimerosal-containing 
vaccines continue to be used throughout the world. Although various government and 
health organizations continue to refute any causal relationship, Geier and Geier (2005) 
noted that vaccine manufacturers continue to advocate for the use of thimerosal in 
pediatric vaccines. 
Speculation about a link between vaccinations and ASD has not been intended to 
scare parents and/or discourage immunization practice. If there is a link then research 
could benefit many children who are highly susceptible to elevated doses of mercury that 
exist in some vaccines.
Given that autism and Asperger’s are pervasive disorders that appear to have 
increased in prevalence, continued research into causes and treatment for these
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devastating disorders is needed. This study contributed to the growing body of literature 
about possible causes associated with the onset of autism spectrum disorders and risk 
factors that impact the current level of autistic symptomology and adaptive functioning. 
Specifically, this study investigated the use of multi-valent and thimerosal-containing 
childhood vaccinations (particularly MMR) and the child’s state of health at the time of 
immunization and their possible link to the onset of ASD. It is hypothesized that a 
weakened immune system/poor health may compromise a child’s susceptibility to 
adverse reactions of vaccinations. Additionally, factors related to pre- and post natal
experiences, were examined to determine their contribution to the current level of autistic 
symptomology and adaptive functioning associated with an individual’s diagnosis. It is 
not believed that any particular factor alone is associated with increased severity of ASD.
It was investigated whether parent risk characteristics (a family history positive for 
psychological and learning disorders, length of gestational period, and maternal illness 
during pregnancy) as well as the presence of child risk characteristics (e.g., physical 
sensitivity, impaired social interaction, developmental regression and 
stereotypical/unusual behaviors) to a marked degree during the first five years of a child’s 
life predict an individuals’ current level of autistic symptomology and adaptive 
functioning.
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CHAPTER II
REVIEW OF LITERATURE
Autism and its related syndromes have attracted the interest and concern of 
clinicians and researchers, from the time it was first described in scientific terms 
approximately 60 years ago by Leo Kanner. Autism, Asperger’s, and PDD are severe and 
life long disorders that affect socialization, language, communication, cognitive 
functioning, and behavior. These disorders have been studied in the areas of 
developmental psychology, neurobiology, therapeutic treatment, and education. The 
literature is filled with examples of theories that have examined the impairments and 
symptomology associated with autism spectrum disorders. The literature for Asperger’s 
specifically, however, is lacking in comparison because it was not readily recognized in 
the United States until the 1990’s, when Asperger’s original paper (published in 1944) 
was translated to English. Despite the abundance or lack of literature for each disorder, 
the etiology of autism spectrum disorders continues to be unknown. 
Foundational research for autism and Asperger’s syndromes
Kanner (1943) published an article concerning eleven children whom he had 
encountered through his clinical practice and whom were believed to exhibit 
characteristics of infantile autism. As Volkmar and Lord (1999) stated: 
Kanner noted that his patients exhibited a disorder characterized by a profound
lack of social engagement from, or shortly after, their birth....his cases also
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exhibited a range of communication problems and unusual responses to the
inanimate environment as well (p. 2).
Kanner noted that these children exhibited a number of common characteristics. Through 
his individual and collaborative work with Eisenberg in 1956 five diagnostic criteria were 
established. The following criteria were noted from Eisenberg & Kanner (1956, pp. 556-
557), Kanner (1943, pp.) and Wing (1981, pp. 93-94):
1. A profoundly impaired ability to exhibit affective contact with other people. “The children’s 
inability to relate themselves in the ordinary way to people and to situations from the 
beginning of life.”
2. A failure to use language for interpersonal communication. Noted by Wing as kind of 
“mutism”.
3. An anxiously obsessive need for the perpetuation of sameness. With interference of the 
pattern/routine to result in episodes of anger or extreme anxiety.
4. “A fascination for objects, which are handled with skill in fine motor movements.”
5. The presence of “good cognitive potential” with distinguishably strong skills in memory and 
use of language.
In 1944, Hans Asperger had published an account of children with several 
similarities to Kanner’s autism but who had greater abilities, including language and 
cognitive skills that appeared in the average or above average range. Although Asperger 
was not aware of Kanner's work on autism, he also used the word autism to describe the 
social deficits he observed in a group of boys. Asperger did not specifically define 
diagnostic criteria, instead he described several commonalities of the children he saw. As 
noted by Wing (1998) and Gillberg (1985) he emphasized the following features:
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1. The children were socially odd, naïve, inappropriate, and emotionally 
detached from others.
2. They had a marked degree of egocentricity and were particularly sensitive to 
any perceived criticism. They were unmindful to others feelings.
3. They had good grammar skills and extensive vocabularies. There speech was 
described as pedantic and literal and they were noted to have difficulty with 
reciprocal conversation.
4. They had poor nonverbal communication skills and their voice lacked 
intonation when speaking.
5. They had restricted interest in facts related to specific subject matter or for 
collections.
6. Despite their average to above average cognitive abilities they appeared to 
have difficulty learning in conventional ways.
7. They displayed poor motor coordination and organization.
8. They appeared to lack common sense.
There are continuing debates concerning the relationship between Asperger and 
Kanner syndromes yet it is undisputable that they have in common impairments of social 
interaction, communication, and restricted, repetitive patterns of activities (Wing, 1981; 
1991). Similarities between Kanner’s and Asperger’s syndrome were described by Wing 
(1998, p. 96) and are summarized in the following points:
1. Both Kanner and Asperger emphasized the marked prevalence of boys over girls.
2. Both syndromes are characterized by a child’s tendency to be egocentric, socially 
isolate themselves, and to have little interest in feelings and ideas of others.
3. Both noted problems regarding the way language was used, as well as the lack of use 
to engage in and/or maintain reciprocal conversations. Impaired non-verbal skills were 
also noted by both.
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4. Both described a lack of imaginative play.
5. A need for repetitive patterns/routines and sameness within the environment was noted 
by both.
6. Both described abnormal responses to “sensory stimuli, including hypersensitivity to 
noise, love of strong-tasting foods and fascination and skill with spinning objects.”
7. Both noted concerns for dexterity of motor skills. While Kanner noted it in some of 
his patients, Asperger described it as a more consistent characteristic. 
8. Both noted behavior problems such as “apparent negativism, aggressiveness to people, 
destructiveness to objects and general restlessness.”
9. Each noted specific strengths for memory skills and numbers.
Despite the obvious similarities, Van Krevelen promoted that the two syndromes were 
distinctly different and noted these differences in 1971 in the first issue of Journal of 
Autism and Childhood Schizophrenia. Van Krevelen (1971) contrasted Kanner and 
Asperger syndromes concluding that they were different but acknowledging that they 
could occur in members of the same family. As Wing (1998) noted:
Van Krevelen listed a number of reasons for regarding the syndromes as different;
for example, a child with early infantile autism walks early and talks late, if at all,
 whereas the converse is true for Asperger syndrome; in autism, speech, if present,
 is not used to communicate, whereas the child with Asperger syndrome tries to
 communicate but in a one-sided way….and that early infantile autism is a
 psychotic process, whereas Asperger syndrome is a personality trait. Further
 suggesting that an autistic child had the genes for Asperger syndrome but became
 autistic because of some perinatal organic brain damage (p. 16).
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Additionally, differences in the onset of some symptoms were notably different with the 
children described by Asperger developing language/speech prior to age 3 and commonly 
portraying extensive and impressive vocabularies (Wing, 1998).
Kanner’s early theoretical views regarding the etiology of autism were often the 
subject of debate in years to follow. Ambivalence of theories and viewpoints concerning 
the etiology of autism plagued not only Kanner but others as well. Kanner first suggested 
that the symptoms exhibited of autism stemmed from an “innate inability for 
interpersonal contact, implying that a disturbance in the growth of the brain is 
responsible” (Trevarthen et al., 1996, p. 48). Kanner eventually placed greater importance 
on the emotional coldness and obsessive qualities of parents and concluded “that 
although the children had some inborn defect, nevertheless in part the disorder was due to 
lack of affection from the parents - that autism was partly a psychogenic disorder due to 
“emotional refrigeration” (Rutter, 1968, p. 1). Trevarthen et al. (1996) noted that Kanner 
first presented autism as a disorder of affective contact. Kanner postulated that the 
emotional characteristics of the mother, with a possible link to high intelligence and 
upper social class of the parents, could be a cause. Kanner would later ascribe to opinions 
that appeared to relieve parents of guilt in relation to the impairments their children 
exhibited and instead promoted theories that were encompassing of the interplay between 
nature and nurture.  
Early research on Asperger’s syndrome was predominately confined to non-
English speaking countries until 1981 when Wing published an extensive review of 
literature and case studies and then again in 1991 when Frith published a translation of 
Asperger’s original paper from 1944. By the time Asperger’s syndrome was recognized 
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in the United States, researchers had established that biological and genetic factors were 
highly associated with the development of autism (Rutter, 1977). And even though the 
two disorders shared similarities the etiological basis of Asperger syndrome was still 
speculative (Gillberg, 1985).
Terminology
Kanner (1943) paved the way for additional theoretical viewpoints to be 
considered that could help explain and define this phenomenon. Disagreement among 
researchers has long been evident when naming these disorders, defining the symptoms 
associated with autism spectrum disorders, and determining their etiology. Many 
different diagnostic labels have been used to characterize the large group of young 
children, such as; psuedoretardation, atypical development, symbiotic psychosis, 
childhood schizophrenia, infantile psychosis and autistic psychopathy (Ornitz & Ritvo, 
1968; Rutter, 1968; Volkmar & Lord, 1998; Wing, 1989). The major criteria for the 
diagnosis of early infantile autism, established by Kanner in the 1940’s, were the 
“inability to relate to people in the expected manner, failure to use language for 
communication, an apparent desire to be alone and to preserve sameness in the 
environment, and preoccupation with certain objects” (Ornitz & Ritvo, 1968). Asperger 
did not specify diagnostic criteria but simply reported on the characteristics and 
symptomology that was exhibited by his subjects. These characteristics were noted 
above.
The term psuedoretardation referred to the fact that many of these children 
appeared retarded while also indicating some intellectual potential, which distinguished 
them from the general population of retarded individuals. The term atypical development 
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was used to refer to children who exhibited “uneven ego development” (Ornitz & Ritvo, 
1968). Symbiotic psychosis was used by Mahler (1952) to describe children who 
appeared to exhibit behavior opposite of those with autism. The term childhood 
schizophrenia was often used as either an interchangeable term for early infantile autism 
or to describe a separate disorder/syndrome. As Volkmar and Lord (1998) noted: 
The controversy surrounding the nature of autism and the dearth of careful
research studies impeded progress for many years. Starting in the 1970’s,
however, there was a growing appreciation that autism was indeed a distinctive
condition, not simply the earliest manifestation of childhood schizophrenia (p. 8).  
Reiser (1963) recommended the term infantile psychosis to describe the time in which the 
pathological process develops during the first fives years of life. He suggested the term 
was all inclusive and therefore should replace all other terminology proposed. Reiser 
(1963) indicated:
The designation “psychotic” is merited by virtue of impairment in perception, 
Failure to test reality, social isolation and withdrawal, impaired control of
instinctual energies, and disturbances of feeling, thinking, and behavior (p.78).
Although Asperger’s syndrome would eventually be named after him, Asperger initially 
used the term autistic psychopathy to describe the abnormal personality traits he was 
noticing in his subjects (Wing, 1989). Even though Asperger was not well known or 
mentioned by many of the early researchers (e.g., Adams, 1973; Robinson & Vitale, 
1954) the descriptions of individuals within their studies indicated they likely exhibited 
Asperger’s syndrome. A number of researchers prior to and following Kanner and 
Asperger pushed for these children with known impairments of social interaction, 
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communication, and stereotyped behavior to be grouped together as one single condition, 
namely, childhood psychosis, which at the time was regarded as a variant of 
schizophrenia (Bender, 1947; Rank, 1949; Szurek, 1956). 
Theoretical Viewpoints and Etiologies
As the terminology used to describe autism evolved, so did a number of theories 
presented by researchers during the 1950’s and 1960’s. As research on autism was 
beginning in the 1960’s there was little consensus of facts. As noted by DeMyer (1975), 
most researchers of this time did agree that the children they were seeing exhibited 
significant social withdrawal and impaired communication skills while also observing 
that they were of high socioeconomic status, had few or no siblings, and were more 
commonly male. Despite the variation of opinions regarding many aspects of the 
disorder, most researchers theories could be categorized into one of three major views: 
“(i) defective parental nurture, (ii) defective biological system in the child (“nature”) or 
(iii) defective “nature-nurture” interaction” (DeMyer, 1975, p. 433).
Psychogenic etiologies/nurture-b ased theories
As a result of Kanner’s early theoretical statements, several interpretations of 
deficient parental nurture were proposed during the 1950’s, 1960’s, and even into the 
1970’s. These theories assumed that the infant was born normal and that the development 
of symptoms was attributable to poor nurturing. Two versions that dominated the early 
research indicated that parents of autistic children had higher amounts of
psychopathology than other parents and/or that they possessed personality types or traits 
that were considered extremely negative. These various theories have postulated that the 
parents of autistic children were deficient either in touching, in feeding practices, in 
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speech practices and/or in eye-to-eye contact with the child, or were thought to project 
dehumanizing fantasies onto their infant….They were viewed as extreme personality 
types; either very depressed, or cold, or full of rage, or without a sense of self, or actually 
psychopathic (Anthony, 1958; Eisenberg & Kanner, 1956; Ekstein, Seymour, & 
Friedman, 1974; Fraknio & Ruttenberg, 1971; King, 1975; Masse, 1978; Szurek, 1973; 
Williams & Harper, 1973; Victor, 1983). Eisenberg and Kanner (1956) even suggested 
that the children themselves show a “full emergence of the latent structure” while the 
parents themselves represent a milder manifestation (p. 561). Researchers of this time 
elaborated on this argument when suggesting that ASD was mainly due to psychogenic 
factors (Bettelheim, 1967; Despert, 1951; Goldfarb, 1961; Meyers and Goldfarb, 1961; 
Kaufman, Rosenblum, Heim et al., 1957). Ferster (1961) indicated that autism was due to 
faulty learning and that the autistic child had not been conditioned properly by his or her
parents. Additional researchers, who attributed autism to the presence of extreme levels 
of psychopathology in the parents, further offered a plausible explanation indicating that 
the infant could simply be mimicking the extreme personality traits of the parent(s) 
(Eisenberg & Kanner, 1956) or, as Szurek (1956) stated, the psychotic child was a 
“magnified mirror opposite” of the unhealthy parent personalities (p. 533). 
Many other authors and researchers who were influenced by emotional trauma in 
infancy as a cause for psychiatric disorders were additionally eager to proclaim their 
theories on the subject. Bettelheim (1967), who was deeply impressed by the serious 
mental illness of children who had experienced extreme neglect or maltreatment, 
concluded that an unsympathetic and neglectful mother could be responsible for the 
‘empty fortress’ state of mind of a child with autism. Indicating that the child resorts to 
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autism as a response to their seemingly hopeless environment. Bettelheim explained the 
severity of the child’s response as dependent upon the critical period in which the neglect 
occurred and suggested that the lack of language and emotionality was due to an 
inattentive audience within his or her environment. Bettelheim also noted that the reason 
siblings were not affected was because the parent’s rejection was specific to the autistic 
child during one or more critical periods of development. Additional researchers such as 
Anthony (1958) and Eisenberg and Kanner (1956) added to this theory indicating that not 
only could deficient parental nurture be a cause for autism but that it could support its 
continued development. Through all of the variations of the deficient parental nurture 
theories, the belief that parents inadequately provided stimulation to their autistic infants 
was consistently emphasized (Anthony, 1958; Bettelheim, 1967; Despert, 1951; 
Eisenberg & Kanner, 1956; Ferster, 1961; Meyers & Goldfarb, 1961; Kaufman et al., 
1957; Szurek, 1956). Ferster (1961) took a behavioral approach and proposed 
reinforcement and consequences in the context of the parent-child relationship caused the 
autistic disorder. Ferster (1961) even suggested that the autism could be weakened or 
eliminated if the parent employed systematic techniques. Reiser (1963) and Szurek 
(1956) postulated that autism resulted when the parent experienced an episode of great 
emotional distress during the critical period of infancy which subsequently compromised 
the parent-child relationship.
Clinicians responded to the notion of deficient parental nurture as a cause for 
autism with psychotherapy as the choice of treatment. It was hypothesized that 
psychotherapy would be able to address the emotional needs of both the parents and 
child. Kanner (1952) wrote that the condition usually could not be remedied because the 
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parents sabotaged treatment....Therefore, unless the mothers could be helped by 
psychotherapy, the only hope for most of these autistic children was to remove them from 
the home and subsequently place them with foster mothers. Therapy was also believed to 
be beneficial to the intellectual abilities that were hidden within the autistic child. Hence 
the “nurture” theorist believed that normal biological intelligence was locked within the 
autistic child....If the right treatment could be found, the child would accelerate in 
progress and eventually become normal or even supernormal in intelligence (DeMyer, 
1975).
However, as controlled studies were completed throughout the 1970’s, it became 
evident that the parents of autistic individuals did not exhibit a greater amount of 
psychopathology (Cox et al., 1975), extreme or unusual personality traits (McAdoo & 
DeMeyer, 1978) nor were any particular patterns of poor infant/child care noted 
(Cantwell, Rutter, & Baker, 1978). Additional studies evidenced that autistic children 
were not solely the product of families from any particular socioeconomic class or race 
(Schopler, Andrews, & Strupp, 1980; Wing 1980). 
Biological etiologies/nature-based theories
In contrast to the nurture theories evident during the 1950’s and 1960’s was the 
opposing biological theories of the cause for ASD. This perspective inferred the cause 
resided in some biological abnormality within the individual, with emphasis on 
deficiencies of the central nervous system and brain. Rimland was one of the first 
researchers to suggest that parents themselves may not be at fault and that there may be 
some other etiological explanation for autism. Rimland opposed Eisenberg and Kanner’s 
(1956) efforts to diminish the importance of the “heredity versus environmental” question 
30
in autism along with their efforts to attribute the genesis of ASD to family dynamics. In 
contrast, Rimland (1964) and others (e.g, Anthony, 1958; Bender, 1959; Goldfarb, 1961; 
Rutter, 1965; Schopler et al., 1980, and Wing, 1976) suggested the involvement of 
organic factors. Rimland (1964) suggested the involvement of a biological deficiency 
associated with the reticular activating system. While Rimland (1964) suggested the 
autism was caused by the under-activity of the reticular system, Hutt, Hutt, Lee et al. 
(1965) suggested autism was due to over-arousal. DeMyer (1975) noted that in the pure 
“nature” theory, the parents were viewed as contributing little more to the child’s illness 
than symptom variations....The illness was considered basically the expression of a 
biological abnormality. While nature theorist did agree that the cause of autistic disorders 
was due to some biological abnormality within the child, most investigators disagreed 
about the kind of biological dysfunction that might be attributing to the presence of 
autism in the individual (Anthony, 1958; Bender, 1959; Fish, 1960; Goldfarb, 1961; 
Knobloch & Passamanick, 1975; Rimland, 1964; Rutter, 1965; Schain & Yannet, 1960; 
Schopler et al., 1980, Wing, 1976). 
Rimland’s proclamations in 1964 brought about a surge of research.  In order to 
diffuse the deficient parental nurture theories and gain evidence to focus on issues related 
to biological factors, investigators began studying parents of autistic children and 
comparing them to other control groups. Researchers found little if any differences 
between the two groups when examining various factors related to the interactions of 
parents and children (Byassee & Murrell, 1975; Cantwell et al., 1978; Cantwell & Baker, 
1978; Cox et al., 1975; Frank et al., 1976; Goldfarb, Spitzer, & Endicott, 1976; and 
McAdoo & DeMyer, 1978). The literature on parents of autistic children produced during 
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the late 1960’s and 1970’s was reviewed by McAdoo and DeMyer (1978). They 
concluded that, as a group, parents of autistic children: a) displayed no more signs of 
mental or emotional illness than parents whose children have “organic” disorders, with or 
without psychosis; b) do not have extreme personality traits such as coldness, obsessive 
ness, social anxiety or rage; and c) do not possess specific deficits in infant and child 
care. With a remarkable amount of evidence against deficient parental nurture as a cause 
for autism, researchers could now focus their attention on biological causes. 
Several theories were introduced by researchers during the 1950’s and 1960’s that 
claimed autism was predominately due to an organic brain disease or possible biological 
or physiological factors (Rutter, 1968). Rimland (1964) and Hutt et al. (1965) suggested 
the involvement of the reticular activating system, Schain and Yannet (1960) suggested 
the limbic system as a site of cerebral abnormality relating to the disorder, while
Fish (1960) suggested the timing mechanism related to somatic development. Still others 
claimed that autism was due to organic brain disease related to conditions such as 
encephalopathy (Bender, 1947) or damage that had occurred during pregnancy or the 
delivery process (Bender, 1947; Knobloch & Passamanick, 1975). Bender suggested a 
disturbance in the rate of development and “emphasized a maturational lag at the 
embryonic level as being characteristic of and fundamental to the development of the 
entire syndrome” (Ornitz & Ritvo, 1968, pp. 87-88). Anthony (1958), Goldfarb (1961), 
Schopler et al. (1980), Rutter (1965), and Wing (1976) suggested that the autistic child’s 
inability to respond normally to stimuli indicated a defect in perception. A more recent 
study conducted by Steffenburg (1991) concluded that 85% to  90% of ASD subjects 
evidenced some indication of underlying brain dysfunction.
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Disturbances related to perception were suggested by several researchers. 
According to this view language was noted as the primary abnormality and that the 
abnormal development of language was similar to impairments involving deficits in 
comprehension or “cognitive auditory inperception” (Rutter, 1965). Researchers noted 
the similarities to include the autistic child’s lack of response to sounds as indicated by 
the lack of a startle response (Anthony, 1958; Rutter 1966), suspected deafness (Kanner, 
1943) and a frequent inability to be distracted (Rutter, 1966). It was further postulated by 
Ornitz and Ritvo (1968) that:
Autistic children do not have the ability to maintain constancy of perception due
to an underlying failure of homeostatic regulation within the central nervous
system so that environmental stimuli are either not adequately modulated or are 
unevenly amplified….resulting in a random underloading or overloading of the 
central nervous system (p. 88).
As early as 1949, Bergman and Escalona observed abnormal sensory responses and 
suggested a low tolerance for external stimulation as being an important role in autism. 
Others studied perceptual difficulties from the notion of receptor preferences. Inferring 
that autistic children exhibited a notable preference for tactile sensation versus visual or 
auditory (Goldfarb, 1956) claiming this as evidence that early sensory deficits were 
linked to inadequate reticular arousal mechanisms (Schopler, 1965).
The research regarding the etiology of Asperger’s syndrome specifically was 
scarce and was often perceived as evidencing similar etiology as classic autism. Asperger 
himself considered it to be genetically transmitted (Gillberg, 1985; Wing, 1981). 
Mnukhin and Isaev (1975) suggested organic brain dysfunction as the basis of the 
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disorder. Wing (1981) described cases where pre-, peri- or post- natal conditions may 
have been associated with brain damage as well as a case which suggested an argument 
for genetic predisposition (Burgoine & Wing, 1983). Research related to perceptual and 
sensory deficits brought about theories suggesting the interaction between biological and 
environmental factors and their impact on the etiology of ASD. 
Etiologies related to the interaction of psychogenic and biological factors
In addition to the nature and nurture theories proposed during the 1950’s and 
1960’s, a variety of combined nature-nurture theories were also postulated (Anthony, 
1958; Mahler, 1952; Mahler & Gosliner, 1955; Rank, 1955, Rimland, 1964; Sarvis & 
Garcia, 1961). There were two main views of the nature-nurture interaction theory. In one 
version all autistic infants were seen as biologically deficient and the parents viewed as 
failing to give proper emotional support….In another version, some infants were viewed 
as organically damaged and others as biologically normal, with the parents of nonorganic 
infant described as failing to a greater degree than parents of organic infants (Coleman 
and Gillberg, 1985, p. 5; DeMyer, 1975, p. 434). Studies that have investigated the 
prevalence of autism among identical twins have provided clear evidence of a strong 
hereditary component combined with environmental factors. As Rimland (1964) noted, it 
is of interest that in several cases of identical twins stricken with autism, the degree of 
affliction, while invariably severe, is not quite identical….This suggests that while 
genetic factors may predispose toward autism, post-conceptional factors could be 
operative.  
Anthony (1958) expanded on his theory regarding the lack of responsiveness in 
the child by further indicating that autistic disorders were caused by a combination of 
34
unresponsiveness in the child and unresponsiveness of the mother. Mahler (1952) 
suggested that autistic syndromes, which were called symbiotic psychosis, stemmed from 
a combined defective ego and a pathogenic mother-child relationship. The mother was
emphasized as an etiological agent by not allowing the child to differentiate himself 
(Mahler  1952; Mahler & Gosliner, 1955). Her theory of separation-individuation 
detailed the child’s struggle or failure to psychologically separate himself from his 
mother. Both Mahler (1952) and Anthony (1958) proposed that a “normal autistic stage” 
existed from the time of birth until the age of two month in which the infant was unable 
to see themselves independently of their mother. They further suggested that the 
pathology emerged if the child remained or returned to this stage. In contrast, Rank 
(1955) suggested a variety of dysfunctions that affected a child’s social interactions and 
their impact on the ability to modulate anxiety. Sarvis and Garcia (1961) and Williams 
and Harper (1973) associated ASD with multiple organic and environmental etiologies 
such as faulty family psychodynamics, traumatic circumstances within the environment, 
significant physical illness, cerebral defects, and other neuropathology affecting 
perception.
The need for classification to support empirical research 
With the work of Kolvin and Rutter (1998) establishing autism as a separate 
disorder from schizophrenia the need for a standard classification was evident, as the 
different definitions and characteristics used to describe autism at times appeared to 
impede research. Among the early attempts to create a more precise definition, Rutter 
(1978) was the most influential. His definition not only included basic concepts of 
Kanner’s early descriptions but he also recognized the need for additional research. 
35
Rutter (1978) suggested four essential features for the diagnosis: (1) an onset prior to 30 
months of age, (2) impaired social development (not associated with any type of mental 
retardation), (3) impaired development in communication which was not related to any 
form of cognitive delay, and (4) the presence of unusual behaviors. These concepts 
appeared to shape the first official categorical definition of autism.
With the 1980 publication of the Diagnostic and Statistical Manual –Third Edition 
(DSM-III) autism was awarded diagnostic status for the first time. The information 
included within the DSM-III reflected heavily the research that had accumulated over the 
previous decade. The condition was included under a new category of disorders, the 
Pervasive Developmental Disorders (PDD), and was referred to as Infantile Autism. As 
Volkmar et al. (1997) noted; the newly termed category, PDD was “meant to convey that 
individuals with these conditions suffered from impairment in the development and 
unfolding of multiple areas of functioning” and was also intended to “avoid a theoretical 
presupposition about etiology” (p. 15). Childhood Pervasive Developmental Disorder, 
Atypical PDD, and Residual Infantile Autism were also included. Atypical PDD was 
used for individuals who appropriately fit into this category but did not meet enough 
criteria for a diagnosis of Infantile Autism (APA, 1980). Residual Infantile Autism was 
used to refer to individuals who had previously met criteria for autism but no longer did 
so (APA, 1980). However, the inclusion of the term residual autism created false hope as 
it implied that these children somehow outgrew the condition (Rumsey, Rapoport, & 
Sceery, 1985; Volkmar, Klin, & Cohen, 1997). The definition presented in the DSM-III 
indicated that pervasive symptoms presented during early childhood, yet it did not 
adequately depict that the condition remains with the individual into adulthood (Volkmar 
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& Lord, 1989). Due to these concerns and the need for a broader conception, changes 
were made to the definition with the publication of the DSM-III-R in 1987. Despite its 
shortcomings, the addition of  the PDD category to the DSM-III and DSM-III-R allowed 
for international recognition and testing of the criteria; and more precise information for 
the publication of the DSM-IV.  
In addition to the DSM, was the well recognized system of medical diagnosis 
known as the International Classification of Diseases (ICD). Coincidently, as the DSM-
III-R was being revised so was the ninth edition of the ICD, which allowed for some 
consistency between the two systems (Cohen & Volkmar, 1997). However, the draft of 
the ICD-10 proposed additional categories not included in the DSM-III-R such as; 
Asperger’s Syndrome, Rett’s Syndrome, Childhood Disintegrative Disorder, and 
Atypical Autism (Cohen & Volkmar, 1997). These differences likely influenced the 
revision and 1994 publication of the DSM-IV.  
Diagnostic criteria for Autism Disorder for DSM-IV and ICD-10 are presented in 
Tables 2 and 3. For the diagnosis of autism, at least six criteria must be exhibited, 
including at least two criteria relating to social abnormalities (group 1) and one of each 
relating to impaired communication (group 2) and range of interests and activities (group 
3). In addition, the onset must have occurred prior to age 3, as evidenced by a delay or 
abnormal functioning in social interaction, use of language in social communication, or 
symbolic/imaginative play. The disorder can not be better accounted for by a diagnosis of 
Rett’s Disorder or Childhood Disintegrative Disorder.
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Table 2  
DSM-IV-TR Criteria for Autistic Disorder (299.00)
A. A total of at least six items from (1), (2), and (3), with at least two from (1), and one each from (2) and 
(3):
(1) Qualitative impairment in social interaction as manifested by at least two of the
      following:
(a) Marked impairment in the use of multiple nonverbal behaviors such as eye-to-eye gaze, facial 
expression, body postures, and gestures to regulate social interaction;
(b) Failure to develop peer relationships appropriate to developmental level;
(c) Markedly impaired expression of pleasure in other people’s happiness;
(d) Lack of social-emotional reciprocity.
(2) Qualitative impairments in communication as manifested by at least one of the following:
(a) Delay in or total lack of, the development of spoken language (not accompanied by an attempt to 
compensate through alternative modes of communication such as gestures or mime);
(b) In individuals with adequate speech, marked impairment in the ability to initiate or sustain a 
conversation with others;
(c) Stereotyped and repetitive use of language or idiosyncratic language;
(d) Lack of varied spontaneous make-believe play or social imitative play appropriate to 
developmental level.
(3) Restricted repetitive and stereotyped patterns of behavior, interests, and activities, as manifested 
by at least one of the following:
(a) Encompassing preoccupation with one or more stereotyped and restricted patterns of interest that is 
abnormal either in intensity or focus;
(b) Apparently compulsive adherence to specific nonfunctional routines or rituals;
(c) Stereotyped and repetitive motor mannerisms (e.g., hand or finger flapping or twisting, or complex 
whole-body movements);
(d) Persistent preoccupation with parts of objects.
B.  Delays or abnormal functioning in at least one of the following areas, with onset prior to age 3    
      years: (1) social interaction, (2) language as used in social communication, or (3) symbolic or
      imaginative play.
C.   Not better accounted for by Rett’s Disorder or Childhood Disintegrative Disorder.
American Psychiatric Association. (1994). Diagnostic and Statistical Manual 4th ed. text revision. Washington DC: 
American Psychiatric Association., pp. 75. 
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Table 3  
ICD-10 Criteria for Childhood Autism (F84.0)
A. Abnormal or impaired development is evident before the age of 3 years in at least one of the following 
areas:
(1) receptive or expressive language as used in social communication
(2) the development of selective social attachments or of reciprocal social interaction;
(3) functional or symbolic play
B. A total of six symptoms from (1), (2), and (3) must be present, with at least two from (1) and at least 
one from each of (2) and (3):
(1) Qualitative impairments in social interaction are manifest in at least two of the following areas:
a. Failure adequately to use eye-to-eye, facial expressions, body postures, and gestures to regulate social 
interaction;
b. Failure to develop (in a manner appropriate to mental age, and despite ample opportunities) peer 
relationships that involve a mutual sharing of interests, activities, and emotions;
c. Lack of socialemotional reciprocity as shown by an impaired or deviant response to others people’s 
emotions; or lack of modulation of behavior according to social context; or a weak integration of social, 
emotional, and communicative behaviors;
d. Lack of spontaneous seeking to share enjoyment, interests, or achievements with other people (e.g., a 
lack of showing, bringing, or pointing out to other people objects of interest to the individual)
(2) Qualitative abnormalities communication as manifest in at least one of the following areas:
a. Delay in, or total lack of, development of spoken language that is not accompanied by an attempt to 
compensate through the use of gestures or mime as an alternative mode of communication (often 
preceded by a lack of communicative babbling);
b. Relative failure to initiate or sustain conversational interchange (at whatever level of language skill is 
present), in which there is reciprocal responsiveness to the communications of the other person;
c. Stereotyped and repetitive use of language or idiosyncratic use of words or phrases;
d. Lack of varied spontaneous make-believe play or (when young) social imitative play.
(3) Restricted, repetitive, and stereotyped patterns of behavior, interests, and activities are manifested 
in at least one of the following:
a. An encompassing preoccupation with one or more stereotyped and restricted patterns of interest that are 
abnormal in content or focus; or one or more interests that are abnormal in their intensity and 
circumscribed nature though not in their content or focus;
b. Apparently compulsive adherence to specific nonfunctional routines or rituals;
c. Stereotyped and repetitive motor mannerisms that involve either hand or finger flapping or twisting, or 
complex whole-body movements;
d. Preoccupations with part-objects or nonfunctional elements of play materials (such as their odor, the feel 
of their surface, or the noise or vibration they generate).
C. The clinical picture is not attributable to the other varieties of pervasive developmental disorders; 
specific developmental disorder of receptive language(F80.2) with secondary socioemotional 
problems’ reactive attachment disorder (F94.1) or disinhibited attachment disorder (F94.2); mental 
retardation (F70-F72) with some associated emotional or behavioural disorders; schizophrenia (F20.-) 
of unusually early onset; and Rett’s Syndrome (F84.12).
World Heath Organization (1993). International Classification of Diseases, 10th ed. Diagnostic Criteria for Research. 
Geneva: World Health Organization, (pp.209).
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Over the next decade the definition and characteristics associated with diagnosing 
autism would continue to evolve to its present status included in the recent edition of the 
DSM-IV-TR (2000) text revision. As noted by Cohen & Volkmar (1997), “from the start, 
DSM-IV was conceptualized as a more sweeping update of the nosology, based on 
detailed evaluation of current data….They considered issues involving clinical utility, 
reliability, and descriptive validity of categories and criteria (p. 18). While Autism 
Disorder and Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) 
had been included in the ICD-9 and the DSM-III /DSM-III-R it was not until the ICD-10
and DSM-IV were published that Asperger’s Syndrome was included. The lack of 
recognition in the United States and absence of an acceptable definition among clinicians 
and researchers contributed to confusion about the validity of this diagnostic concept 
(Cohen & Volkmar, 1997; Volkmar, 1998; Wing, 1981, 1991, 1998, 2005). Although 
Asperger’s Syndrome had been included in the ICD-10, its validity as a separate disorder 
from autism had not yet been established and would continue to be questioned even after 
its inclusion in the DSM-IV (Cohen & Volkmar, 1997; Woodbury-Smith et al., 2005; 
Wing, 1981, 1991, 1998, 2005). It is further suggested by Woodbury et al. (2005) that 
this confusion was due to limitations inherent to the criteria. Even the most recent 
revision of the DSM-IV, the DSM-IV-TR which was published in 2000 indicated that 
definitive data related to the disorder is limited. 
Diagnostic criteria for Asperger’s Disorder for DSM-IV-TR are presented in 
Table 4. In the ICD-10 (1993), DSM-IV and DSM-IV-TR the disorder differs from autism 
in that there is a lack of any clinically significant delay in language or cognitive 
development and self-help and adaptive behavior skills are within normal range of 
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development. In people with Asperger's Syndrome, deficits in social interaction and 
unusual responses to the environment, similar to those in autism, are observed. Unlike in 
autism, however, cognitive and communicative developments are within the normal or 
near-normal range in the first years of life, and verbal skills are usually an area of relative 
strength. Idiosyncratic interests are common and can be exhibited in unusual and/or 
highly limited interest (e.g., a specific animal such as dinosaurs, in bus/train schedules, 
various flavors of gum).The ICD-10 and DSM-IV-TR also state that motor delays and 
motor clumsiness are typically exhibited but does not require they be present for 
diagnosis. As with autism, both the ICD and DSM definitions indicate that Asperger’s 
Syndrome can not be attributed to other varieties of PDD or schizophrenia. For the 
diagnosis of Asperger’s at least three criteria must be exhibited, including at least two 
criteria relating to social abnormalities (group 1) and one relating to impaired range of 
interests and activities (group 2). In addition, it must cause impairment in social or 
occupational functioning; there can be no clinically significant delay in language, 
cognitive development, or adaptive behavior and other PDD’s and schizophrenia must be 
ruled out.
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Table 4  
DSM-IV-TR Criteria for Asperger’s Disorder (299.80)
A. Qualitative impairment I social interaction, as manifested by at least two of the following:
(1) Marked impairment in the use of multiple nonverbal behaviors such eye-to-eye gaze, facial expression, body 
postures, and gestures to regulate social interaction.
(2) Failure to develop peer relationships appropriate to developmental level.
(3) A lack of spontaneous seeking to share enjoyment, interests, or achievements with other people (e.g., by lack 
of showing, bringing, or pointing out objects of interest to other people).
(4) Lack of social or emotional reciprocity.
B. Restricted repetitive and stereotyped patterns of behavior, interests, and activities as manifested by at 
lest one of the following:
(1) Encompassing preoccupation with one or more stereotyped and restricted patterns of interest that is abnormal 
either in intensity or focus.
(2) Apparently inflexible adherence to specific, nonfunctional routines or rituals.
(3) Stereotyped and repetitive motor mannerisms (e.g., hand or finger flapping or twisting, or complex whole-
body movements).
(4) Persistent preoccupation with parts of objects.
C. The disturbance causes clinically significant impairment in social, occupational, or other important 
areas of functioning.
D. There is no clinically significant general delay in language (e.g., single words used by age 2 years, 
communicative phrases used by age 3 years).
E. There is no clinically significant delay in cognitive development or in the development of age-
appropriate self-help skills, adaptive behavior (other than in social interaction), and curiosity about the 
environment in childhood.
F. Criteria are not met for another specific Pervasive Developmental Disorder or Schizophrenia.
American Psychiatric Association. (1994). Diagnostic and Statistical Manual 4th ed. text revision. Washington DC: 
American Psychiatric Association., pp. 84.
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With the publication of the DSM-IV the term atypical autism, which had been included in 
the ICD, was added under the subcategory of Pervasive Developmental Disorder Not 
Otherwise Specified. This subcategory was designed for diagnosis of individuals who 
exhibited severe pervasive impairments for some or all of the proposed symptomology 
but did not specifically meet the criteria for any particular Pervasive Developmental 
Disorder, Schizophrenia, Schizotypal Personality Disorder, or Avoidant Personality 
Disorder (APA, 1994).   
Genetic etiologies
More than 20 years would pass after Kanner and Asperger’s original descriptions 
before genetics was recognized as important to the etiology of ASD. With standard 
diagnostic criteria in place research appeared to regain its purpose. New causes for ASD 
would become the focus of research particularly with the technological advancements 
available to researchers. After twin studies during 1970’s and 1980’s concluded there 
may likely be a genetic component (Rimland,1964) etiological research began efforts to 
uncover genetic links. Of particular interest was determining chromosomal influence and 
the possibility of locating a specific gene(s) related to ASD (Petit, Herault, Martineau et 
al., 1996; Philippi, Roschmann, Tores et al., 2005; Skuse, 2000; 2005; Trottier, 
Srivastava, & Walker, 1999; Wassink, Piven, Vieland et al., 2005). 
There are different genetic disorders in which those affected have higher rates of 
autism than would be expected (Folstein & Rosen-Sheidley, 2001). ASD has been 
associated with disorders such as Fragile X Syndrome, untreated phenylketonuria (PKU), 
neurofribromatosis, and tuberous sclerosis (Gillberg & Forsell, 1984; Gillberg & Rutter 
et al, 1997; Trottier et al., 1999).  Although no disease gene has been definitely identified 
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with the etiology of ASD (Wassink et  al., 2005) researchers appear to be getting closer. 
Studies also supported the involvement of the X chromosome as influential in ASD (Petit 
et al., 1996; Skuse, 2000). Regions of particular chromosomes (e.g., chromosomes 2, 4, 
7, 10, 16, 18, 19, and 22) have been associated with ASD (Philippi et al., 2005; Trottier et 
al., 1999; Wassink et al., 2005). Of particular interest to researchers has been 
chromosome 15 as it appears to be a common site for abnormalities associated with 
autism (Folstein & Rosen-Sheidley, 2001; Rutter et al., 1997). Etiological relevance for 
this chromosome comes from the association of various regions with disorders such as 
dyslexia (Trottier et al., 1999), Prader-Willi (Martin, State, Koenig et al., 1998) and 
Angelman syndrome (Nurmi, Bradford, Chen et al., 2001).  
Pre- peri- and postnatal factors and infectious etiology
One of the questions raised in early literature from the 1960’s about autistic
syndromes was the possibility of an infectious etiology to the syndrome (Chess, 1971, 
1977, Chess et al., 1971; Crook, 1983; Desmond et al., 1967; Dykens & Volkmar, 1997; 
Freedman et al., 1970; Gillberg, 1985; Knobloch & Passamanick 1975; 1970; Rutter, 
1977). Although research concerns today have advanced this notion, it indicates that a 
concern regarding children’s weakened immune systems and susceptibility to 
psychological illness was recognized. These early studies portrayed concerns regarding 
pre- and post-natal infectious diseases and the impact on children’s immune systems as a 
result of these infections. Studies were conducted that investigated whether children who 
experienced pre- or post- natal infections and/or a suppressed immune system developed 
autism (Chess, 1971, 1977; Chess et al., 1971; Coleman & Gillberg, 1985; Dykens & 
Volkmar, 1997; Knobloch & Passamick, 1975; Kennedy et al., 2004; Krause et al., 2002; 
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Ritvo & Ritvo, 1982; Stubbs & Magenis, 1980). It has been noted that a small but 
significant proportion of children develop an autistic disorder as a result of pre-or post-
natal infections; for example with rubella, cytomegalovirus, herpes, and others (Gillberg 
& Coleman, 1992).
In 1979, Deykin and MacMahon conducted a retrospective epidemiological study 
of 163 autistic children and their unaffected siblings by using parent interviews and 
medical reports. They found a small number of cases in which infectious etiology could 
be established, indicating that the viruses studied were unlikely to have contributed to 
autism. However, in summary Deykin and MacMahon (1979) noted that for the children 
identified as partially autistic that there was a statistically significant difference between 
cases and sibling controls in their exposure to or illnesses of the mother with prenatal 
rubella as well as an increased frequency of maternal illnesses (rubella and mumps). For 
fully autistic patients they found that prenatal maternal influenza was four times as 
common and that during the postnatal period the exposure to mumps was greater (Deykin 
& MacMahon, 1979). Later studies also assessed risk factors related to utero exposure 
with the use of birth-defect causing substances such as ethanol, valproic acid and 
prescriptive drugs (Rodier, 2000). Although the evidence somehow escaped earlier 
researchers, evidence linking the use of  thalidomide, an anti-nausea drug used with 
expectant mothers in the 1960’s, with some cases of autism was discovered by Stromland 
et al. (1994). Their findings suggested that ASD may originate as early as the first few 
weeks of pregnancy, when the embryo’s brain and nervous system are just beginning to 
develop (Stromland et al., 1994). Stromland et al. evaluated Swedish adults born between 
the late 1950’s and early 1960’s who exhibited malformations due to thalidomide 
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exposure (stunted arms and legs, misshaped or missing ears and thumbs, and neurological 
dsyfunctions of the eye and facial muscles). Because of advanced knowledge of 
embryonic development, stages of organ development related to pregnancy were useful in 
pinpointing exact times that malformations occurred for the subjects. Stromland et al. 
discovered that most thalidomide victims with autism had malformations in the external 
part of their ears but none associated with the arms or legs….indicating they had been 
injured during the early stages of gestation, possibly 20-24 days after conception. 
    Research regarding post-natal infection and autism was particularly sparked by 
the Rubella epidemic that occurred in 1964 (Chess 1971, 1977; Chess et al. 1971; 
Coleman & Gillberg, 1985). In a study conducted by Chess et al. (1971) it was found that 
out of 243 children studied they identified 18 as having “an autistic syndrome” and eight 
more who had a “partial syndrome of autism” (p. 35). However, the significance of this 
finding was modified by follow-up data, collected by Chess et al. (1977) indicating that 
these identified children, as they grew older, ceased to exhibit autistic symptoms. 
Additional researchers have also reported cases of children developing autism upon 
experiencing various post-natal infections (Crook, 1983; Desmond et al., 1967; Freedman 
et al., 1970; Gillberg, 1985; Knobloch & Passamanick 1975). Even in the early literature,
a small amount of evidence suggested that infectious agents in the post-natal period may 
have been a factor in the development of autistic syndromes. The suggestion that autism 
could be caused by vaccination has been in circulation for many years; however, the 
amount of literature that exists is often inconsistent (Bernard et al., 2001; Bernard et al., 
2002; Coleman & Gillberg, 1985; Kennedy et al., 2004; Krause et al., 2002; Shattock & 
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Savery, 1997). Additionally, there is a period of time in which the literature appears to be 
lacking the investigation of this topic.
Wakefield et al. (1998, 2000) has been a primary investigator in researching the 
link between ASD and the MMR multi-component vaccination. Hilts (2000) reported 
Wakefield became interested in investigating the possible link between MMR and autism 
in response to reports from parents whose experience of autism seemed to be different 
from the usual…parents reported an onset of autism rather suddenly, over a period of 
months, and often just after vaccination with the MMR multi-component vaccine. 
Research findings from a case study of 30 children, reported by Wakefield during 1998 
conference proceedings of Pyschobiology of Autism, indicated that onset of behavioral 
symptoms was associated, by the parents or referring physician, with MMR vaccination 
in 11 of the 30 children studied…and that the data provided further support for a link 
between autism and vaccination. An additional investigation by Wakefield et al. (1998) in 
which 12 children were included produced similar results supporting evidence for a 
possible link between MMR and autism…it was reported that:
In eight children, the onset of behavioral problems had been linked, either by the
parents or by the child’s physician, with measles, mumps, and rubella
vaccination…Five had had an early adverse reaction to immunization (rash,
fever, delirium; and in three cases, convulsions)…In these eight children the
average interval from exposure to first behavioral symptoms was 63 days (with a
range of 1-14 days) (p. 639).
Singh (2000) related additional evidence in support of a link between the MMR vaccine 
and autism spectrum disorders. He spoke of research related to autoimmunity and its
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explanation for a link between vaccines and autism and other autoimmune diseases. 
Singh (2000) indicated that he had coined a term “Autoimmune Autism” (AA) to refer to 
a subset of autism that has autoimmune etiology….and that he believes there are 
“scientific reasons to think that this subset may indeed be a result of vaccine injuries to 
children who display autistic regression” (¶2). He further noted that the “autoimmune 
response is what happens in autoimmune diseases such a lupus,”…and that his research 
“showed a similar response may account for the brain abnormalities found in people with 
autism” (¶3). “The hallmark of autoimmune diseases is the organ-specific autoantibodies 
that have also been identified in people with autistic disorder” (Singh, 2000, ¶4). “A 
summarization of approximately 400 cases (autistic and controls) found that up to 80% of 
autistic children have autoantibodies to specific brain structures”…and that 
“autoantibodies are present quite frequently (60-85%) in autistic children, but only rarely 
(0-5%) in normal children and other disease controls”  (Singh, 2000, ¶4). Based on the 
belief that autoimmunity is commonly triggered by environmental exposures such as viral 
infections, Singh (2000) investigated a virus link with autoimmunity and ASD which 
posed the following questions; 1) Do autistic children have a hyperimmune response (or 
increase of antibodies) for a specific virus? and 2) Is there a relationship between virus 
antibodies and brain autoantibodies in autism? Singh’s (2000) findings indicated that :
There was indeed a hyperimmune response to a virus and it was specifically for
the measles virus…there was an association between measles virus antibodies and
myelin basic proteins autoantibodies (i.e., the higher the measles virus antibody
level the greater the chance of brain autoantibody.)” (¶5).
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Earlier research by Singh (1998) indicated that many autistic children had antibodies to a 
specific protein of the measles-mumps-rubella vaccine. These findings led Singh to 
speculate that autism might be caused by a measles or MMR vaccine-induced 
autoimmune response. Others have also noted adverse events following MMR 
vaccination in immunodeficent patients (Kennedy et al., 2004; Krause et al., 2002). It was 
noted by Kennedy et al. (2004) that certain instances exist in which it is contraindicated 
for individuals with defective immune systems to receive vaccines. These instances 
include pregnancy, immune dysfunction, febrile illness, a history of allergic reactions to 
antibiotics, and HIV.
Additional research conducted by Geier and Geier (2003, 2004, 2005) also 
indicated a relationship between increasing doses of mercury from thimerosal-containing 
vaccines and neurodevelopmental disorders such as autism. Specifically, they found a 
relationship between the thimerosal-containing vaccine DTaP and neurodevelopmental 
disorders. In their 2004 study, they investigated the effects of administration of tens of 
millions of doses of thimerosal-containing vaccines to millions of children. Furthermore, 
Geier and Geier’s (2003, 2004, 2005) findings supported earlier studies conducted by 
Barnard et al. (2001) and Bradstreet et al. (2003)  which hypothesized that children who 
were diagnosed with autism spectrum disorders had a decreased ability to expel mercury 
when compared to normal control groups. This inability to excrete mercury was noted as 
particularly troubling by Gasset, Motokazu, Yasuo, and Ramer (1975). Gasset et al. 
(1975) showed that the administration of thimerosal to animals resulted in a high 
concentration of mercury in the blood and tissue (including the brain), further concluding 
that thimerosal crosses the blood-brain barrier. Additionally, Bernard et al. (2002) noted 
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that in his review of the research, preliminary findings suggested that mercury may 
persist in the tissue of some autistic individuals and may contribute to autistic symptoms.
Perhaps, some of the most fascinating data thus far that is supportive of a possible 
causal link between the MMR vaccination and ASD comes from the Vaccine Adverse 
Event Reporting System (VAERS). Kennedy et al. (2004) reported that between January 
1990 and January 2001, 291 unique reports from the United States were identified that 
involved MMR and another poly/multi-valent vaccine and adverse affects such as 
autism… and that of the 129 reports involving autism, 46% were from the MMR vaccine 
alone. The evidence is scarce in support of a link between vaccines and ASD in 
comparison to evidence refuting a link. There are several examples in the literature that 
indicate a lack of support and/or evidence for a link between the MMR vaccine and 
autism spectrum disorders. Hilts (2000) indicated that “mainstream medical organizations 
and leaders in the field of immunization agree that there is not convincing evidence for 
the theory that the vaccine, MMR, for measles, mumps, and rubella, causes autism” (p. 
20).
Several researchers who conducted systematic reviews of the literature found no 
evidence proposing a link between MMR and ASD (Bower, 1999; DeStefano & Chen, 
1999; Klein & Diehl, 2004; Nicoll, Elliman, & Ross, 1998). Jefferson, Price, Demicheli 
et al. (2003) conducted a review of the literature to evaluate the unintended effects 
associated with MMR. Jefferson and his colleagues found that MMR was linked, to a 
varying degree, with conditions such as upper respiratory infections, irritability, and 
aseptic meningitis but that no link was evident for conditions such as Autism, Crohn’s 
disease, and ulcerative colitis. They concluded that the adverse event could not be 
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alienated from its role in preventing the intended disease. Time trend analysis were also 
conducted to assess the association between MMR and the increased prevalence of ASD 
in the United States (Dales, Hammer, & Smith, 2001), European countries (Taylor et al.,
1999) or both (Stehr-Green, Tull, Stellfeld et al., 2003). However, results indicated no 
causative association or one that is exceedingly rare (Honda, Shimizu, & Rutter, 2005).
Makela, Nuroti, and Peltola (2002) conducted a retrospective study involving hospital 
discharge records in order to assess the possible association between MMR and ASD. 
They found no clustering of hospitalization for ASD following immunization nor an 
association between MMR vaccination and ASD. Fombonne and Chakrabarti  (2001) 
tested the claim that there was a new phenotype of ASD (autistic entercolitis) that 
involved gastrointestinal symptoms but found no support for MMR induced autism or 
autistic entercolitis. Peltola et al. (1998) conducted a study in which 14 years worth of 
data from the National Board of Health and National Public Health Institute was 
reviewed. The findings indicated that a “decades effort to detect all severe adverse events 
associated with MMR vaccine could find no data supporting the hypothesis that it would 
cause pervasive developmental disorders” (Peltola et al., 1998, p. 1328). A study 
conducted by Madsen, Hviid, Vestergaard, Schendel et al. (2002) reviewed records of 
537,303 children born in Denmark between January 1991 and December 1998. Of those 
children, 440,655 had been vaccinated. The authors found that the risk of autism was 
similar in children who were vaccinated and children who were not as well as that there 
was no increase in the risk of an autistic disorder among vaccinated compared to 
unvaccinated children. A large study completed by Taylor et al. (1999) in which 
approximately 500 children diagnosed with autism were investigated, found no relation 
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between the children’s vaccination dates and the onset of their disease. The study found 
that although the number of cases of autism disorders had been increasing since 1979, 
there was no significant increase following the introduction of the multi-valent MMR 
vaccine. Taylor et al. (1999) also noted that children vaccinated before 18 months of age, 
after 18 months of age, or not vaccinated, were similar in age at diagnosis, further 
indicating that vaccination does not appear to result in an earlier onset of autism. Taylor 
et al. (1999) further notes that these findings “confirm and extend studies from Sweden 
(Gillberg & Heijbel, 1998), and Finland (Peltola et al., 1998), both of which 
demonstrated no relationship between MMR vaccination and autism” (p. 2028). Offit 
(2000), during a government reform hearing, attempted to invalidate proposed theories 
relating to the association of vaccination and autism. Offit (2000) discussed counter 
points to theories related to autoimmunity reactions, the use of  multi-component 
vaccines, and the unnatural route/methods by which vaccines are administered.
There is an increasing amount of research presently being conducted into the 
possible link between autism and vaccinations. Some of this stems not only from 
concerned parents voicing their experiences related to autism but experiences related to 
side effects experienced from other vaccines as well. As reported by Hsu (1999) the “US 
got a wake up call between 1989 and 1991 when measles inoculations lapsed among 
preschool children in some urban areas…55,000 people got sick and 120 died, most of 
them children under 5” (p. C1). Additional examples noted by Hsu (1999) included a 
recent concern over the rotavirus causing a rare and dangerous bowel disorder, seizures 
as a result of a new strain of the Pertussis vaccine and the chicken pox vaccine, as well as 
paralization from polio vaccines. In fact, in 1986 the Vaccine Adverse Event Reporting
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System (VAERS) was established for parents and/or doctors to report vaccine related 
injuries and side effects.   
This increase in current research has resulted from the elevated incidence of parents 
claiming that their child’s autism was the result of, or compounded by, vaccination. 
These parents often describe distressing accounts of extremely rapid regression, from 
perfectly average developing children to children who begin to exhibit severe behavioral 
and physiological problems. Clinicians, researchers, and parents alike would agree that 
by the very definition of autism, a period of regression often accompanies the onset of 
autism, but the timing of vaccinations with autism, by some is simply interpreted as mere 
coincidence.  
A vaccine is intended to help an individual’s body establish immunity to a 
specified disease by creating antibodies, but on occasion it can cause an illness that is 
unrelated to the actual disease it is created for. Those who dispute the safety of 
vaccinations indicate their concerns are related to a particular ingredient, thimerosal, an 
ingredient used as a preservative since the 1930’s. The preservatives are used in vaccines 
to prevent microbial growth and are added during the manufacturing process. “They are 
used in vaccines to prevent microbial growth in the event that the vaccine is accidentally 
contaminated, as might occur with repeated puncture of multi-dose vials” (Egan, 2004 
section titled Thimerosal Reduction in Vaccines,¶1). Egan (2004) further noted that it is 
routine to add preservatives to multi-dose vials because when they did not contain 
preservatives in the past tragic consequences occurred. 
Although the level of mercury within any individual vaccine is not harmful, the 
additive amount of mercury that is contained in the usual dosage of vaccines given during 
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one visit could allow an excessive amount of mercury, which exceeds government-
recommended levels, to be ingested. As of 1999, both the FDA and the American 
Academy of Pediatrics (AAP) had determined that the typical amount of mercury injected 
into infants and toddlers via childhood immunizations has exceeded government safety 
guidelines on an individual (Halsey, 1999) and cumulative vaccine basis (Egan, 1999 in 
Bernard et al., 2001). Geier and Geier (2005) further noted that the levels of mercury 
children are exposed to not only exceed the Federal Safety Guidelines but that it also 
exceeds the United States Environmental Protection Agency’s permissible hair mercury 
limit. showed that exposure to low doses of methyl mercury during the prenatal period 
was associated with minor neurodevelopmental abnormalities (Cox et al., 1989; Marsh et 
al., 1987; Redwood et al., 2001). And children are given an aggressive dosage of 
vaccines throughout their first year of life. Bernard et al. (2001) stated that “exposure to 
mercury can cause immune, sensory, neurological, motor and behavioral dysfunctions 
similar to traits defining or associated with autism” (p. 462). Bernard et al. (2001) notes 
the similarities between ASD and mercury poisoning. Bernard et al. (2001) noted that 
autism is perceived as a psychiatric disorder and that mercury poisoning, when 
undetected, is often initially diagnosed as a psychiatric disorder. Commonly occurring 
symptoms associated with mercury poisoning were noted by Bernard et al. (2001): (a) 
Extreme shyness, indifference to others, active avoidance of others, or a desire to be 
alone; (b) depression, lack of interest and mental confusion; (c) irritability, aggression, 
and tantrums in children and adults, (d) anxiety and fearfulness; and (e) emotional 
labiality. When Bernard et al. (2001) reviewed the diagnostic criteria for autism and 
compared it to symptomology associated with mercury poisoning there were several 
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similarities. They found similarities for impairments in speech/communication, physical 
movement, and sensory issues. 
Additional concerns regarding this notion of vaccinations and their link to the 
cause of ASD is the claim that a dramatic increase in the number of children identified 
was seen in relation to the introduction of the multi-component MMR vaccine (Bernard, 
2000; Shattock & Savery, 1997; Taylor et al., 1999). 
There is little evidence, even anecdotal evidence, that the older, single component
vaccines, could result in such problems as autism.  Reports of such problems
appear after the introduction of the multi-component MMR vaccine (1988 in the
UK)…If these reports are correct it would seem that it is the combination which is
responsible for these problems…Given the fact that the Measles virus is known to
be immunosuppressant, its inclusion in combination with other disease causing
organisms is, in any case, inherently problematic” (Shattock & Savery, 1997,
¶15).
Additionally, as Bernard et al. (2001) noted: 
In studies conducted prior to 1970, autism prevalence was estimated, at 1 in 2000;
in studies from 1970 to 1990 it averaged 1 in 1000.…In the early 1990’s, the
prevalence was found to be 1 in 500, and in 2000 the CDC found 1 in 150
affected in one community, which was consistent with reports from other areas in
the country. In the late 1980’s and early 1990’s, two new thimerosal containing
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vaccines, The HIB and Hepatitis B, were added to the recommended schedule (p. 
466).
As a result of the controversy, the Food and Drug Administration (FDA) reviewed 
thimerosal-containing products. In 1999, the FDA discovered that “children could be 
exposed to an amount of mercury from vaccines that exceeded 1 of 3 existing federal 
safety thresholds” (Freed et al., 2002, p. 1153). In response to the findings related to 
safety guidelines being exceeded, the FDA requested that the vaccine manufacturers 
eliminate thimerosal wherever it was deemed possible. As of 2001, thimerosal in 
quantities sufficient to act as a preservative was reportedly removed from all vaccines 
included in the United States childhood immunization schedule, except for some 
influenza vaccines (FDA, 2003). However, there are still trace amounts of thimerosal 
present in some vaccines to ensure sterility that are added as a result of the manufacturing 
process. These trace amounts are reportedly so small that exposure is insignificant (Freed 
et al., 2003; Parker et al., 2004). Because most multi-dose vials are being replaced with 
single-dose vials excessive amounts of thimerosal as a preservative are no longer present 
in most recommended vaccines in the United States, for children younger than 7 (Egan, 
2004; Parker et al., 2004). However, thimerosal-containing vaccines continue to be used 
throughout the world. Furthermore, Organizations such as the Immunization Safety 
Review Committee of the Institute of Medicine continue to refute any causal relationship 
between exposure to thimerosal and various neurodevelopmental disorders (Parker et al., 
2004) and the World Heath Organization and several vaccine manufacturers continue to 
advocate for the use of thimerosal in pediatric vaccines (Geier & Geier, 2005).
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Factors contributing to the variation in severity of autism spectrum disorders
In addition to researching etiology of ASD, of interest were other factors which 
may have contributed to the severity or level of symptomology among individuals. While 
the symptoms associated with ASD often occur with varied intensity it is not completely 
understood what attributes to these variations among individuals. As Rimland (1964) 
noted, it was of interest that in several cases of identical twins stricken with autism, the 
degree of affliction was not identical, suggesting that while genetic factors may 
predispose toward autism, post-conceptional factors could also be operative. Research is 
somewhat inconsistent due to the varied methodologies in defining and assessing severity 
as well as varied classification criteria used over the decades (Glasson et al., 2004). It was 
highly evident upon review of the literature that the concept of severity has not been well 
defined; as interpretations varied widely among researchers and clinicians, when it was 
even recognized. Defining severity, as it pertains to ASD, can include assessment of 
adaptive behavioral functioning, standard scores from cognitive and/or diagnostic rating 
scales, or by the number of symptoms exhibited. For the purpose of this study, severity 
was defined by standard scores on adaptive functioning and specific diagnostic rating 
scales and referred to as the child’s level of autistic symptomology and level of adaptive 
functioning. 
Adaptive skills are involved in coping with day to day demands within the 
environment and are of particular importance for autistic individuals as they are means of 
determining the level of supervision needed (Liss, Harel, Fein, et al, 2001). Most children 
with ASD have some degree of impairment in adaptive functioning (Liss et al., 2001). As 
well, the degree of diagnostic criteria/symptomology exhibited can be helpful in 
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determining individual strengths and weaknesses as they relate to adaptive skills.  
Information related to adaptive functioning and symptomology along with other 
prognostic data can be helpful in determining the severity of the disorder. But little is 
known on what variables correlate specifically with adaptive functioning and diagnostic 
criteria in predicting the severity of ASD. 
The literature is significantly lacking in studies that specifically investigate 
possible predictors of severity (as defined by this study) for ASD. The few studies that do 
exist did not address the specific question of this study and employed a variety of 
methodologies. In addition it is noted that the concept of severity was not consistently 
measured by standardized instruments. Liss et al. (2001) investigated correlates and 
predictors of adaptive functioning as measured by the Vineland Adaptive Behavior 
Scales in children with high and low functioning autism. They found that adaptive 
behavior was strongly correlated with autistic symptomology. Dawson, Meltzoff, 
Osterling et al. (1998) studied autistic children’s performances on neuropsychological 
task as a predictor of severity. Severity was defined by the frequency of behavioral 
symptoms exhibited on a structured task. Dawson et al. (1998) found that for children 
with autism, the severity of autistic symptoms was strongly and consistently correlated 
with their performance on a task requiring use of the medial temporal lobe. Examination 
of autistic children has also shown that the severity of autistic disorders correlates with 
the amount of testosterone present in the amniotic fluid (Geier & Geier, 2004), however 
the study did not specify how severity was defined and/or measured.  
It is noted that the literature that follows makes little reference to severity of ASD, 
rather the investigators reported on increased occurrences of pre-post natal factors found 
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among autistic groups. This literature has been included because the variables studied 
were similar to those investigated in the current study, however, the current study 
investigated their impact on severity (as defined above) rather than their association with 
causation. Although not assessing severity, additional researchers found common factors 
among the medical history of autistic patients. Field, Garland, and Williams (2003) 
indicated that feeding problems were commonly found among children with ASD as well 
as other developmental disabilities. Semple (2004) found that prenatal exposure to 
teratogens/toxins, perinatal difficulties, febrile seizures, severe reactions to medications 
and/or vaccinations, and a positive family history for autism were reported with greater 
occurrence among autistic children. Gillberg and Cederlund (2005) found that 
approximately 50% of all boys with Asperger have had a paternal family history for 
ASD. A study by Lock, Shapiro, Ross et al. (1986) examined the relationship between the 
age at which a developmental disability presents itself and factors such as medical illness, 
motor skills, language skills, and behavioral disturbances. They found that information
related to motor, language, and behavior was a better predictor for age of onset than 
severity of the disorder. Additional researchers have reported significantly higher 
incidences of pre and post natal difficulties among autistic children. Most commonly 
investigated factors found to occur with greater incidence included; sleep disturbances 
(Clements, Wing, & Dunn, 1986; Patzold, Richdale, & Tonge, 1998; Polimeni, Richdale, 
& Francis, 2005; Rapin, 1991), obstetric complications (Burd, Severud, & Kerbeshian, 
1999; Glasson et al., 2004; Park & Bolton, 2001; Wilkerson, Volpe, Dean, et al., 2002), 
low birth weight (Bhutta, 2002; Indredavik, Vik, Heyerdahl, et al., 2004; Knobloch & 
Passamanick, 1975; Finnegan & Quarrington, 1979; McCormick, 1997), prenatal 
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exposure to drugs/prescriptive medications (Deykin & MacMahon, 1980; Walker, 
Rosenberg, & Balaban-Gil, 1999), maternal age (Tsai & Stewart, 1983) and maternal 
smoking (Hultman, 2002).
While Patzold et al. (1998), Clements et al. (1986) and Rapin (1991) found that 
children with autistic disorders exhibited clinically significant levels and patterns of 
disruptive sleep; Polimeni et al. (2005) found that those with Asperger’s exhibited even 
greater symptoms and types of sleep disturbance than children with autism. Park and 
Bolton (2001) found that although autistic children had an increased risk of obstetric 
complications there was no correlation between obstetric adversities and the severity of 
the disorder. Finegan and Quarrington (1979) examined original medical records of 
autistic individuals and found that breech presentation during labor, low birth weight, low 
Apgar scores, and respiratory distress were more frequent among autistic children. 
Knobloch and Passamanick (1975) found an increased incidence of low birth weight and 
toxemia/bleeding in the birth histories of autistic children. Wilkerson et al. (2002) 
investigated the association of prenatal complications and autism by having parents of 
autistic and non-autistic children complete the Maternal Perinatal Scale (MPS). They 
found that factors such as prescription drugs used during pregnancy, length of labor, viral 
infection, abnormal presentation at delivery, low birth weight, urinary infection, high 
temperature and maternal depression occurred with greater frequency among the autistic 
group. Although sparse, findings have suggested maternal smoking (Hultman, et al., 
2002) and maternal age (Tsai & Stewart, 1983) as possible risk factors for autism.
Nearly all children in the United States are immunized, yet only a small 
proportion actually develop autism. The etiology of autism has not yet been linked to any 
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one cause. There are several hypotheses proposed for the etiology of autism spectrum 
disorders that have been investigated throughout the last 60 years. While a genetic link 
has been established by research it is likely that both genetic and environmental factors 
attribute to its cause. Concerns dating back to the early 1960’s focused on questions 
related to an infectious etiology as one possible cause for these disorders. This 
questionable link has once again surfaced as a result of both an increase in prevalence of 
autism spectrum disorders and reported causal links of autism to immunization 
administration. In addition to the proposed link of vaccination to the cause of ASD, is the 
question of additional pre-and postnatal factors that attribute to the variation of 
symptomology and adaptive functioning and therefore severity among autistic children. 
Given the variability in ASD, even in groups of children who evidence the same disorder, 
it seems likely that environmental factors play an important role in the development of 
these disorders as well as influence severity. 
This study investigated whether exposure to various environmental events during 
pre-, peri-, or postnatal periods predict the onset of autism and severity of autism 
spectrum disorders. Specifically, it investigated whether parent risk characteristics (a 
family history positive for psychological and learning disorders, length of gestational 
period, and maternal illness during pregnancy) and the presence of child risk 
characteristics (e.g., physical sensitivity, impaired social interaction, developmental 
regression and stereotypical/unusual behaviors) to a marked degree during the first five 
years of life predict an individuals current level of autism symptomology and adaptive 
functioning.
61
CHAPTER III
METHODOLOGY
Overview, Statement of Questions and Hypotheses
Research related to the etiology of ASD indicates both genetic and environmental 
components may be important causal factors. However, predicting the importance of each 
of these factors has been challenging for researchers. Nevertheless, it is likely that autism 
has a multifactor origin. There is evidence indicating pre- and postnatal exposure factors, 
genetic predisposition, and environmental catalyst, are in part responsible for the onset 
and severity of the disorder. This study investigated the relationship of multi-valent and 
thimerosal-containing childhood vaccinations (particularly MMR), the child’s state of 
health at the time of immunization and the onset of ASD. The relationship of various 
environmental events during pre-, peri-, or postnatal periods with the levels of current
autism symptomology and adaptive functioning was also examined. The following 
questions and hypotheses were proposed:
Question 1: Does exposure to thimerosal-containing vaccines during scheduled 
vaccination(s) predict the onset of an autism spectrum disorder?
Hypothesis 1: The exposure to thimerosal-containing vaccines during scheduled
vaccination(s) does predict the onset of an autism spectrum
disorder.
62
Question 2: Does exposure to a multi-valent and thimerosal-
containing vaccination, particularly MMR, predict the onset of an 
autism spectrum disorder?
Hypothesis 2: The exposure to a multi-valent and thimerosal-containing 
vaccination, particularly MMR, does predict the onset of an autism 
spectrum disorder.
Question 3: Does the child’s state of health at the time of vaccination predict
the onset of an autism spectrum disorder?
Hypothesis 3: The child’s state of health at the time of vaccination does predict
the onset of an autism spectrum disorder.
Question 4: Do child risk factor characteristics (physical sensitivity, 
impaired social interaction, developmental regression, and 
stereotyped or unusual behaviors) displayed to a marked 
degree during the first five years of life predict current
levels of autism symptomology?
Hypothesis 4: Child risk factor characteristics (physical sensitivity, 
impaired social interaction, developmental regression, and 
stereotyped or unusual behaviors) displayed to a marked 
degree during the first five years of life do predict current
levels of autism symptomology.
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Question 5: Do child risk factor characteristics (physical sensitivity, 
impaired social interaction, developmental regression, and 
stereotyped or unusual behaviors) displayed to a marked
degree during the first five years of life predict current
levels of adaptive functioning in children with ASD?
Hypothesis 5: Child risk factor characteristics (physical sensitivity, 
impaired social interaction, developmental regression, and 
stereotyped or unusual behaviors) displayed to a marked
degree during the first five years of life do predict current
levels of adaptive functioning in children with ASD.
Question 6: Do parent risk characteristics (maternal or paternal family history 
of psychological disorder or learning problems, length of 
gestational period, and maternal illness during pregnancy) predict 
current levels of autism symptomology?
Hypothesis 6: Parent risk characteristics (maternal or paternal family history of 
psychological disorder or learning problems, length of gestational 
period, and maternal illness during pregnancy) do predict current 
levels of autism symptomology.
Question 7: Do parent risk characteristics (maternal or paternal family history 
of psychological disorder or learning problems, length of 
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gestational period, and maternal illness during pregnancy) predict 
current levels of adaptive functioning?
Hypothesis 7: Parent risk characteristics (maternal or paternal family history of 
psychological disorder or learning problems, length of gestational 
period, and maternal illness during pregnancy) do predict current 
levels adaptive functioning.
Participants
Participants were children diagnosed with an autism spectrum disorder (autism, 
Asperger’s, or pervasive developmental disorder) who were born after 1971. Participants 
born prior to 1971 were excluded from the study because the multi-component MMR 
immunization was not utilized in the United States until after this time. Participants 
ranged from 2 to 23 years of age, with the average age being 9.17 years (4.6 SD). 
Information regarding developmental, medical, family, and diagnostic history, as well as 
details of immunizations was obtained. Assessment information related to adaptive 
behavior functioning and the child’s autism spectrum disorder was also obtained to 
determine the level of the autistic disorder symptomology and adaptive behavior 
functoining. Participants were considered to have ASD if the parent reported the child
had been diagnosed through a multidisciplinary evaluation within the public school 
setting or by a licensed psychologist. Demographic data including age, gender, education, 
and race of both the participant and his/her parents were requested. Demographic data are 
summarized in Table 5. 
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Independent Variables
Multi-Valent and Thimerosal-Containing Immunizations
The receipt of multi-valent and thimerosal-containing immunizations was the first 
independent variable. All immunizations were included as thimerosal is used as a 
preservative in these vaccines. Models were created with each set of immunizations 
received at the proposed age comprising a block. Five blocks were created; Block 1 = 
Immunizations received at 2 months: DTP, HepB, Polio, Influenza; Block 2 = 
Immunizations received at 4 months: DTP, HepB, Polio, Influenza; Block 3 = 
Immunizations received at 6 months: DTP, Influenza; Block 4 = Immunizations received 
at 12-15 months: DTP, HepB, Polio, MMR, Varicella; and Block 5 = Immunizations 
received at 4-6 years: DTP, Polio, MMR. Receipt of vaccination was determined from 
immunization history requested on the developmental and medical history form 
questionnaire.
Measles-Mumps-Rubella Immunization
The receipt of the multi-valent and thimerosal-containing MMR vaccine was the 
second independent variable. This immunization is received by children between the ages 
of 12-15 months and again between 4-6 years of age. Receipt of the MMR immunization 
was determined from immunization history requested on the developmental and medical 
history form questionnaire.
State of Health at the time of Immunization
The child’s state of health at the time of vaccination was the third independent 
variable. In addition to requesting information related to immunization history, parents 
were asked to indicate whether their child was sick or healthy at the time of 
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immunization. Sick at the time of immunization was defined as the child experiencing a 
compromised state of health (e.g., suffering from a cold, virus, infection, or fever). 
Models were created for state of health (sick vs. healthy) with each set of immunizations 
received at the proposed age comprising a block. Five blocks were created; Block 1 = 
Sick at the time of immunizations received at 2 months: DTP, HepB, Polio, Influenza; 
Block 2 = Sick at the time of immunizations received at 4 months: DTP, HepB, Polio, 
Influenza; Block 3 = Sick at the time of immunizations received at 6 months: DTP, 
Influenza; Block 4 = Sick at the time of immunizations received at 12-15 months: DTP, 
HepB, Polio, MMR, Varicella; Block 5 = Sick at the time of immunizations received at 
4-6 years: DTP, Polio, MMR. State of health at the time of immunization was determined 
from immunization history requested on the developmental and medical history form 
questionnaire.
Child Risk Characteristics
Independent variables related to child risk characteristics were also examined in 
relation to current levels of ASD symptomology and adaptive functioning. These 
included the presence of a sibling diagnosed with ASD or other medical or psychological 
conditions, achievement of developmental milestones (e.g., sitting, rolling, crawling, 
walking, speaking, dressing independently), and experience of various factors to a 
marked degree during the first five years of life (e.g., high fevers, poisoning, illness, 
behavioral oddities). A detailed questionnaire was utilized to obtain information related
to these characteristics. A copy of the developmental and medical history form is 
included in the appendix. Correlations among each of the dependent variable rating scales 
standard scores and the independent variables were calculated to determine which of the 
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independent variables were most related to the dependent variables. Items were chosen 
based on theoretical framework and their significance at the .05 and .01 levels. This
exploratory technique was used to reduce the original number of variables; 1) physical 
sensitivity, 2) impaired social interaction, 3) developmental regression, and 4) 
stereotypical/unusual behaviors. Physical sensitivity was comprised of items related to 
the child’s difficulty being calmed, dislike of being held, and general sensitivity. 
Impaired social interaction was comprised of items relating to poor eye contact, starring, 
and difficulty interacting with others. Developmental regression was comprised of items 
endorsing or refuting a slowness to speak and roll over, and an observable loss of 
developmental skills. Stereotypical/unusual behaviors was comprised of questions related 
to a child’s display of rocking, toe walking, hand flapping, clumsiness and unusual or odd 
behaviors.
Parent Risk Characteristics
Parent risk characteristics were also examined in relation to current levels of ASD 
symptomology and adaptive functioning. These included the presence of a family history 
positive for various medical, psychological, and learning problems, and exposure to 
various factors during pregnancy (e.g., drugs, prescription or over the counter 
medications, alcohol, tobacco, illness, trauma, toxic chemicals). A detailed questionnaire 
was utilized to obtain information regarding medical and birth history. Correlation was 
used to examine and reduce the original number of variables into three categories, 1) 
parent history of psychological disorders/learning problems, 2) length of gestation, and 3) 
illness during pregnancy. Parent’s psychological history was comprised of items related 
to the family medical history of both parents. Parents of the participants were asked to 
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report whether there was a positive family history for themselves or someone within their 
family for various disorders. The following disorders were included in this variable: 
anxiety, depression, learning disability, and speech-language disorder. Length of 
gestation and illness during pregnancy were comprised from single items/variables.
Length of gestation was reported in weeks with the average gestation established by the 
medical community as 36 weeks.
Instrumentation
Dependent Variables
Age of Onset
The first dependent variable in this study was the child’s age when autism 
spectrum characteristics/symptoms were first noted by parents. This variable was referred 
to as the onset of autism. For the purpose of this study, an individual was considered to 
be autistic if s/he met criteria for an autism spectrum disorder (autism, Asperger’s, or 
PDD) as specified by the DSM-IV.
ASD Symptomology
The second dependent variable in this study was the level of the individuals’ 
autistic symptomology. Level of symptomology was defined by an individuals overall 
standard score obtained on an autism rating scale (Gilliam Autism Rating Scale (GARS) 
or Asperger’s Syndrome Disorder Scale (ASDS)). 
The GARS is a forty-two item standardized behavioral rating scale developed to
identify and diagnose persons who are autistic. It is used to distinguish children with 
autism in the low to moderate range from children with autism in the moderate to high 
range. The GARS assessed the child from the parents’ point of view. The forty-two 
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GARS items are divided into three subtests (Stereotyped Behaviors, Communication, and 
Social Interaction) that describe specific, observable, and measurable behaviors. The 
items were rated using a frequency based rating of 0 to3 (0 = never observed, 1 = seldom 
observed, 2 = sometimes observed, and 3 = frequently observed). Fourteen additional 
items are included for parents to contribute data about their child’s development during 
the first three years of life, however, the completion of these items was not required as
the subject matter was covered within the developmental and medical history form. 
The GARS was normed on a sample of 100 individuals from 21 states, with 
regard for gender, age, ethnicity, and geographic location. Internal consistency for the 
subtests Stereotyped Behaviors, Social Interaction and Autism Quotient yielded 
coefficient alphas of .90 or above, while the Communication subtest alpha was .89 and 
the Developmental Disturbance subtest alpha was .88. The test-retest reliability was 
found to be beyond the .01 level of significance for all subtest. The parent-parent 
interrater reliability subtests coefficients were found to be the weakest of all examined 
but were still significant (p < .01). The parent-parent interrater reliability was found to be 
.83 for the Autism Quotient. 
Content validity was obtained for the following scales: Stereotyped Behaviors .61, 
Communication .65, Social Interaction .69, and Developmental Disturbances .61. 
Criterion-related validity was also found to discriminate the autistic from nonautistic 
sample at a 90% accuracy rate.      
The ASDS is a fifty item standardized behavioral rating scale developed to
identify and diagnose persons with Asperger’s syndrome. It is used to distinguish 
children with Asperger’s in the low to moderate range from children with Asperger’s in 
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the moderate to high range. The ASDS assesses the child from the parents’ point of view. 
The fifty GARS items are divided into five subtests (Language, Social, Maladaptive, 
Cognitive, and Sensorimotor) that describe specific, observable, and measurable 
behaviors. The items are rated using a rating of 0 or 1 (0 = never observed and 1 = 
observed). 
The ASDS was normed on a sample of 100 individuals from 21 states, with 
regard for gender, age, ethnicity, and geographic location. Internal consistency for the 
subtests were lower than the alpha for the Asperger Syndrome Quotient (ASQ) (.83). The 
parent-parent interrater reliability was found to be 96.36 (p < .01) for the ASQ. 
Content validity was obtained for the following scales: Language .55, Social .59, 
Maladaptive .57, Cognitive .47, and Sensorimotor .67. Criterion-related validity was also 
found to discriminate the Asperger from non-Asperger sample at a 85% accuracy rate.      
Adaptive Behavioral Functioning
The third dependent variable in this study was level of the autistic individuals’ 
adaptive functioning. Level of adaptive functioning was defined by an individuals 
standard score obtained on an adaptive behavior scale (Scales of Independent Behavior -
Revised: Short Form (SIB-R)). 
The SIB-R Short Form is a forty item standardized adaptive behavior rating scale 
developed to assess independent living skills. The adaptive behavior scale was used to 
assess information related to the following areas: motor skills, social interaction and 
communication skills, personal living skills, and community living skills.     
Norming data for the SIB-R was obtained from 2,182 individuals from 15 states, 
with regard for gender, age, ethnicity, occupational status and level, geographic location, 
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and type of community. Reliability for the SIB-R was determined using the split-half 
procedure and corrected by the Spearman-Brown formula (Bruininks, Woodcock, 
Weatherman et al., 1996). Internal consistency for the SIB-R Short Form yielded a 
coefficient of .76. The test-retest reliability coefficient for the SIB-R Short Form was .97. 
The interrater reliability among parents was found to be .93. Construct validity was 
obtained by comparison of the SIB and SIB-R using Rasch item calibration. The SIB-R 
Short Form yielded a correlation of .99.      
Developmental and Medical History Form
The developmental and medical history form was developed to obtain demographic 
information, family medical history, and information related to pregnancy/birth, 
developmental achievement, and immunizations received. The questionnaire was a 
compilation of existing clinical intake forms previously used by the author. Items 
included were based on a review of the current literature as well as interest of new 
variables to be examined in the current study.  
Procedure
Participants were solicited through special education programs in Oklahoma and 
parent support groups from across the United States. The directors of special education 
programs and autism support groups/organizations were contacted by phone and/or e-
mail and asked to disseminate information to the parents/members related to participation 
requirements of the study. A cover letter was sent via mail or e-mail to directors/group 
leaders explaining the study which was then disseminated to potential participants. 
Demographic data along with detailed developmental, medical, diagnostic, and 
immunization history were obtained through questionnaire format that was sent and 
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returned via mail. A child was considered for participation in the study if s/he had 
received the majority of immunizations according to the recommended U.S. schedule. It 
is noted that some participants did not receive subsequent immunizations after 15 months 
of age (particularly the MMR shot) after the onset of autism was noted by parents. In 
regard to the questions related to family medical history and exposure to medication and 
toxins during pregnancy, not all known diagnoses and medications could be included, 
therefore space was provided for respondents to provide information. Information not
readily available from the participant that needed to be obtained from school/medical 
records was received after a medical release of information form was signed. Each 
participant received a packet containing an informed consent sheet, release of information 
form, the Gilliam Autism Rating Scale (GARS) or Asperger Syndrome Diagnostic Scale 
(ASDS), an adaptive behavior rating scale (SIB-R Short Form), and a detailed 
developmental and medical history questionnaire requesting the above-mentioned 
information. Participants were guaranteed privacy and anonymity regarding the 
information relayed for the purpose of the study. Participants were not identified by 
name. Identification numbers were used for demographic information, the developmental 
health history form, and the rating scales. All data was secured in a locked file cabinet.
The autism and Asperger’s rating scales were estimated to take approximately 10-15
minutes to complete while the developmental and medical history questionnaire was 
estimated to take approximately 20 minutes to complete. For individuals who had not 
completed a GARS or ASDS for their child within a 12-month period one was provided 
for their completion. 
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CHAPTER IV
RESULTS
This study examined the relationship between various environmental events
during pre-, peri-, or postnatal periods and the onset and severity of autism spectrum 
disorders. The onset of autism, the severity of symptomology, and the level of adaptive 
functioning were used as the dependent variables while the receiving of the MMR 
immunization, the individual’s state of health at the time of vaccination, and various 
factors related to medical, family, and developmental history were used as independent 
variables. The Statistical Package for Social Sciences version 12.0 (SPSS, 2003) was 
used to conduct statistical analysis of the data.  
Both continuous and categorical variables were included in the study. Dummy 
coding was used to code the categorical data obtained from the developmental and 
medical history form, indicating the presence or absence of each variable (e.g., 1= yes, 2= 
no). Descriptive statistics were calculated to describe the participants and are summarized 
in Table 5. Descriptive statistics were also calculated for the dependent variables and are 
summarized in Table 6. Correlations among each of the dependent variable rating scales 
standard scores and the independent variables were calculated to determine which of the 
independent variables were most related to the dependent variables. Items were chosen 
based on theoretical framework and their significance at the .05 and .01 levels. The 
component variables of parent and child risk characteristics were developed. This 
exploratory technique was used because there were too many independent variables to 
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select for regression models and the literature did not allow for strong a priori hypotheses 
to be developed with specific independent variables. Simple linear regression equations 
were calculated to analyze the relation among independent variables and the dependent 
variables (onset of ASD, Level of ASD symptomology, Level of Adaptive Functioning.)
Characteristics of the 114 participants included in the study are summarized in 
Table 5. A proportionately larger amount of the participants were male and Caucasian 
rather than female and other ethnicities. The sample is representative of what would be 
found in the general population. Approximately 60% of the individuals included in the 
study were between 4 and 9 years of age with the average age being 9.17 years (4.6 SD). 
Slightly more than half (55.3%) of the participants had a diagnosis of autism versus 
Asperger’s (28.9%) or Pervasive Developmental Disorder (15.8%). Over half (51.3%) of 
the participants included in the study experienced the onset of autism and received a 
diagnosis by the age of three (47 months). Parents of participants diagnosed with PDD 
were given the option of which autism rating scale was more appropriate for their child. 
The majority (15 of 18) completed the GARS and are therefore categorized with the 
autism group. 
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Table 5
Characteristics of Participants
Characteristic                 n Percent
Gender
Male    94 82.46
Female    20 17.54
Age in months
1-47 (1-3 years)      7   6.14
48-83 (4-6 years)  38 33.33
84-119 (7-9 years)    30 26.32
120-155 (10-12 years)    17 14.91
155-179 (13-15 years)      9   7.89
180-231 (16-18 years)      9   7.89
> 232 (> 19 years)      4   3.51
Race
African American      2   1.77
Caucasian  101 89.38
American Indian 3   2.65
Hispanic 1   0.88
Asian      1    0.88
Other      5   4.42
Diagnosis
Autism    63 55.26
Asperger’s    33 28.95
PDD    18 15.79
Onset of Symptoms/Age of Parental Concerns 
      Noted: in months
1-24 (1-2 years)    76 68.47
25-48 (3-4 years) 26 23.42
60-96 (5-8 years) 9   8.11
Age at Diagnosis: in months
1-47 (1-3 years)    58 51.33
48-83 (4-6 years) 31 27.43
84-119 (7-9 years)    11   9.73
120-155 (10-12 years)    11   9.73
155-179 (13-15 years)      1   0.88
180-231 (16-18 years)      1   0.88
< 232 (> 19 years)      0
Mean Age of Onset = 24.16 months Standard Deviation = 18.38 months
Mean Age of Diagnosis = 56.95 months Standard Deviation = 37.81 months
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Table 6
Means and Standard Deviations of Dependent Variables
Dependent Variable Mean  SD
Age of Onset (in months) 24.16 18.38
Level of Symptomology (GARS SS/Autism Quotient) 92.20 19.84
Level of Adaptive Functioning (SIB-R SS/Broad Indep) 54.37 34.00
Onset of Autism Spectrum Disorder
The mean age at which parents initially noted concerns for their child’s 
development and the onset of an autism spectrum disorder was approximately 24 months 
(2 years) of age, whereas the mean age at which a diagnosis was determined was 56 
months (4.6 years) of age. Of the 114 participants, a high percentage of them were 
administered the recommended vaccinations between 2 and 15 months of age, but a 
significant decrease was noted for the number of participants who received 
immunizations at 4-6 years of age.  Data on influenza was the exception, as some states
have different policies regarding the requirement of this particular immunization. 
Participant’s immunization participation is summarized in Table 7.
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Table 7
Immunizations (U.S. Schedule) Received by Participants
Immunization    n Percent
Diptheria/Tetanus/Pertusis (DTP) 
 2 months 113 99.12
 4 months 112 98.25
 6 months 109 95.61
12-15 months 106 92.98
4-6 years   84 73.68
Hepatitis B
 2 months 101 88.60
 4 months 101 88.60
12-15 months   99 86.84
Polio
 2 months 110 96.49
 4 months 109 95.61
12-15 months 107 93.86
4-6 years   88 77.19
Influenza
 2 months   79 69.30
 4 months   78 68.42
 6 months   77 67.54
Measles/Mumps/Rubella (MMR)
12-15 months 110 96.49
4-6 years   79 69.30
Vericella
12-15 months    96 84.21
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A series of simple linear regression analyses were completed to assess the relation 
between childhood vaccinations, particularly the MMR vaccination, and the participants 
state of health at the time of vaccination with the onset of an autism spectrum disorder. A 
p-value of 0.05 was retained for statistical significance. The single-variable regression 
models confirmed no association between MMR vaccinations and the onset of an autism 
spectrum disorder. However, one variable did approach significance when analyzing its 
effect on the onset of autism; MMR vaccination administered at 4 years of age yielded an 
overall R of .182, F (1,106) = 3.647, p = .059. These findings are summarized in Table 8. 
Table 8 displays the R, R2, adjusted R2, F, degrees of freedom, and p value for the 
regression equations. It is noted that analysis was not possible for the independent 
variable Diptheria/Tetanus/Pertusis at 2 months of age (DPT-2months) as there was no 
variance. Variables were entered as blocks with each set of immunizations received at the 
proposed age comprising a block (e.g., Block 1 = Immunizations received at 2 months: 
DTP, HepB, Polio, Influenza; Block 2 = Immunizations received at 4 months: DTP, 
HepB, Polio, Influenza; Block 3 = Immunizations received at 6 months: DTP, Influenza; 
Block 4 = Immunizations received at 12-15 months: DTP, HepB, Polio, MMR, Varicella; 
and Block 5 = Immunizations received at 4-6 years: DTP, Polio, MMR). No significant 
associations were found among each of the blocks and the onset of ASD. These 
regressions are summarized in Table 9.
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Table 8
Regressions Predicting the Onset of ASD and MMR Immunization
R R2     Adjusted     F df P
R2
Onset of ASD
  Predictor
Measles/Mump/Rubella (MMR)
12-15 months  .030   .001 -.008     .099       1,107            .754
Onset of ASD
  Predictor
Measles/Mump/Rubella (MMR)
4-6 years   .182      .033              .024    3.647       1,106            .059*
Note: * approached significance
Table 9
Regressions Predicting Onset of ASD and Thimerosal-Containing and Multi-Valent
Immunizations
R         R2        Adjusted      F df P
                        R2
Onset of ASD
  Predictors
   Immunizations Received
    Block 1: 2 months   .206 .043        .014 1.483      3,100 .268     
    Block 2: 4 months .227     .051            .013          1.352        4,100            .256
    Block 3: 6 months   .085       .007 -.012      .376       2,104            .687
    Block 4: 12-15 months   .168       .028 -.022      .566         5,98             .726           
    Block 5: 4-6 years   .231    .053             .026    1.957        3,104           .125          
Note: Block 1 = Immunizations received at 2 months: DTP, HepB, Polio, Influenza; Block 2 = Immunizations received at 4 months: 
DTP, HepB, Polio, Influenza; Block 3 = Immunizations received at 6 months: DTP, Influenza; Block 4 = Immunizations received at 
12-15 months: DTP, HepB, Polio, MMR, Varicella; and Block 5 = Immunizations received at 4-6 years: DTP, Polio, MMR
The participant’s state of health at the time of vaccination and the onset of an 
autism spectrum disorder were also examined. Variables were entered as blocks with 
state of health (sick) and each set of immunizations received at the proposed age 
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comprising a block (e.g., Block 1 = Sick at the time of immunizations received at 2 
months: DTP, HepB, Polio, Influenza). Table 10 summarizes the percentage of 
participants who were sick at the time of immunization. No significant associations were 
found among each of the blocks and the onset of ASD. These regressions are summarized 
in Table 11. 
Table 10
Percentage of Participants who were Sick at the time of Immunization
Variable               n Percent
Sick at the time of Immunization 
2 Months
DTP 111 97.36
HepB 100 87.72
Polio 110 96.49
Influenza   77 67.54
  4 Months
DTP 110 96.49 
 HepB 100 87.72
Polio 109 95.61
Influenza   77 67.54
  6 Months
DTP 108 94.73
Influenza   75 65.78 
 
  12-15 Months
DTP 104 91.22
HepB   98 85.96
Polio 107 93.86
MMR 108 94.73
Vericella   94 82.45
  4-6 Years
DTP   83 72.80
Polio   88 77.19
MMR 77 67.54
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Table 11
Regressions Predicting Onset of ASD and State of Health at the time of Immunization
R         R2        Adjusted      F df P
                        R2
Onset of ASD
Predictors
   Immunizations Received
   Block 1: 2 months (sick) .102 .010 -.018 .370  2,70 .692              
Block 2: 4 months (sick)    .175 .030  .03 1.115   2,71 .333
Block 3: 6 months (sick)   .038 .001 -.012 .102   2,72     .750
Block 4: 12-15 months (sick)   .122 .015 -.046 .244   5,81 .942
Block 5: 4-6 years (sick)   .038 .001 -.013 .097 1,68 .757
Note: Block 1 = Sick at the time of immunizations received at 2 months: DTP, HepB, Polio, Influenza; Block 2 = Sick at the time of 
immunizations received at 4 months: DTP, HepB, Polio, Influenza; Block 3 = Sick at the time of immunizations received at 6 months: 
DTP, Influenza; Block 4 = Sick at the time of immunizations received at 12-15 months: DTP, HepB, Polio, MMR, Varicella; Block 5
= Sick at the time of immunizations received at 4-6 years: DTP, Polio, MMR.
Level of Current ASD Symptomology and Adaptive Behavioral Functioning
Independent variables related to risk characteristics displayed by a child within 
the first five years of life were analyzed using linear multiple regression to determine 
their relationship to the participant’s current level of ASD symptomology and adaptive 
functioning. Correlations among each of the rating scales standard scores and the 
independent variables were calculated in order to reduce the original number of variables 
analyzed and create the following component variables; physical sensitivity, impaired 
social interaction, developmental regression, and stereotyped/unusual behaviors. 
Parent risk characteristics were  also analyzed using linear multiple regression to 
determine their relationship to the participant’s current level of autistic symptomology 
and adaptive functioning. Correlations among each of the rating scales standard scores 
and the independent variables were calculated in order to reduce the original number of 
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variables analyzed and create the following component variables; family history positive 
for psychological and learning problems, length of gestation, and maternal illness during 
pregnancy. 
Tables 12, 13 and 14 show the correlations of the independent variables with each 
of the rating scales. Only participants with a diagnosis of Autism or PDD who completed 
the GARS and/or the SIB-R were included in the final analysis related to severity. Those 
diagnosed with Asperger’s and who completed the ASDS were excluded because of the 
small sample size. Although participants who completed the ASDS were excluded, the 
variables parent history of psychological disorders/learning problems and physical 
sensitivity displayed by the child were found to correlate with the ASDS standard score at 
the .05 level.
Table 12
Correlations among the Independent Variables and the GARS Autism Quotient Standard Score
Independent Variable              GARS  
     Autism Quotient
Parent Risk Characteristics
Psychological Disorders/Learning Problems   .259*
Length of Gestation -.305**
Illness during Pregnancy -.030
Child Risk Characteristics
Physical Sensitivity   .304**
Impaired Social Interaction .136
Developmental Regression   .156
Stereotyped/Unusual Behaviors   .420**
Note: *Significant at the p=.05 level, ** Significant at the p=.01 level.,
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Table 13
Correlations among the Independent Variables and the SIB-R Broad Independence Standard 
Score
Independent Variable SIB-R 
   Broad Independence
Parent Risk Characteristics
Psychological Disorders/Learning Problems  .144
Length of Gestation  .072
Illness during Pregnancy -.004
Child Risk Characteristics
Physical Sensitivity -.061
Impaired Social Interaction -.292**
Developmental Regression -.319**
Stereotyped/Unusual Behaviors -.196*
Note: *Significant at the p=.05 level, ** Significant at the p=.01 level.,
Table 14 
Correlations among the Independent Variables and the ASDS Asperger’s Syndrome Quotient 
Standard Score
Independent Variable ASDS
        Asperger’s Syndrome Quotient
Parent Risk Characteristics
Psychological Disorders/Learning Problems  .394*
Length of Gestation  .005
Illness during Pregnancy .055
Child Risk Characteristics
Physical Sensitivity  .376*
Impaired Social Interaction  .007
Developmental Regression -.076
Stereotyped/Unusual Behaviors -.018
Note: *Significant at the p=.05 level, ** Significant at the p=.01 level.,
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Current Level of ASD Symptomology as Assessed by the GARS
Parent Risk Characteristics
Parent risk characteristics (presence of a psychological or learning disorder within 
the family history, length of gestation, and illness during pregnancy) and the level of 
autistic symptomology were examined. All parent characteristic variables were entered
into the equation and referred to as block 1. A significant association was found for 
parent risk characteristics and current level of ASD symptomology. These regressions are 
summarized in Table 15. 
In block 1 the variable psychological or learning disorder within the parent’s
family history accounted for a large portion of the variance. The zero-order correlation
value for the variable is .263. The variable (Psychological/Learning Disorders) in the 
regression accounts for 26.3% of the overall variance in the model. The variable related 
to gestation also accounted for a significant amount of variance. The zero-order 
correlation for length of gestation is -.305, indicating it accounts for 30.5% of the overall 
variance in the model. The variable illness during pregnancy accounted for less than one 
percent. 
Table 15
Regression Predicting Current Level of ASD Symptomology and Parent Risk
Characteristics
R         R2        Adjusted      F df P
                        R2
Level of ASD Symptomology (GARS) 
  Predictors
   Block 1: Parent Char. .402  .161 .126 4.553  3,71 .006              
Note: Parent Char. = Parent Characteristics (Psychological and/or Learning Problems, Length of Gestation, Illness during Pregnancy). 
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Child Risk Characteristics
Child risk characteristics (physical sensitivity, impaired social interaction, 
developmental regression, and stereotypical/unusual behaviors) and the level of autistic 
symptomology were examined. All child characteristic variables were entered into the 
model (block 2). A significant association was found for child characteristics and current 
level of ASD symptomology. These regressions are summarized in Table 16.
In block 2 the variables physical sensitivity and stereotypical/unusual behaviors 
each accounted for a large portion of the variance. The zero-order correlation value for 
the variable physical sensitivity is .304 while the zero-order correlation value for 
stereotypical/unusual behavior is .420. These two variables in the regression collectively 
account for approximately 72% of the overall variance in the model. The variables 
impaired social interaction and developmental regression account for 13% and 15 % of 
the overall variance in the model. 
Table 16
Regression Predicting Current Level of ASD Symptomology and Child Risk
Characteristics
R         R2        Adjusted      F df P
         R2
Level of ASD Symptomology (GARS) 
  Predictors
   Block 2: Child Char. .453 .205 .162 4.779  4,74 .002         
Note: Child Char. = Child Characteristics (Physical Sensitivity, Impaired Social Interaction, Developmental Regression, 
Stereotypical/unusual behaviors).
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Parent and Child Characteristics
A statistically significant relationship was also noted among the dependent 
variable, current level of symptomology as assessed by the GARS, and all seven 
independent variables (Psychological/Learning Disorders, Length of Gestation, Physical 
Sensitivity, Impaired Social Interaction, Developmental Regression, and 
Stereotypical/Unusual Behavior), yielding an overall R of .555, F (7, 67) = 4.256, p < .01. 
This model was referred to as block 3. The presence of both child and parent risk 
characteristics within a participant’s history accounted for a significant amount of 
variance in the current level of ASD symptomology. The R2 value for the model is .308. 
The independent variables in the regression collectively account for 30.8% of the 
variance in the dependent variable. Examination of the zero-order correlations indicated 
each of the following variables attributed significantly to the overall variance of the 
model: Psychological/Learning Disorder = 26.3%, Physical Sensitivity = 29.6%, Length 
of Gestation = 30.5%, and Stereotypical/Unusual Behaviors = 44.4%. Table 17
summarizes the regression.
Table 17
Regression Predicting Current Level of ASD Symptomology and the Presence of Both 
Parent and Child Risk Characteristics
R         R2        Adjusted      F df P
                        R2
Level of ASD Symptomology (GARS) 
  Predictors
   Block 3: Parent/Child Char. .555 .308 .235 4.256  7,67 .001         
Note: Parent/ Child Char. = Parent and Child Characteristics (Psychological and/or Learning Problems, Length of Gestation, Illness 
during Pregnancy, Physical Sensitivity, Impaired Social Interaction, Developmental Regression, Stereotypical/unusual behaviors).
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Current Level of Adaptive Functioning for Individuals with ASD as Assessed by 
the SIB-R 
Parent Risk Characteristics
No statistically significant relationship among current level of adaptive 
functioning, as assessed by the SIB-R, was found for the predictor variables related to 
parent characteristics (block 1). Table 18 shows the regression.
Table 18
Regression Predicting Current Level of Adaptive Functioning and Parent Risk
Characteristics
R         R2        Adjusted      F df P
                        R2
Level of Adaptive Functioning (SIB-R) 
  Predictors
   Block 1: Parent Char. .161 .026 -.002 .926  3,104           .431         
Note: Parent Char. = Parent Characteristics (Psychological and/or Learning Problems, Length of Gestation, Illness during Pregnancy). 
Child Risk Characteristics
A statistically significant correlation was noted among the dependent variable, 
current level of adaptive functioning, and the independent variables related to child risk 
characteristics (block 2). Table 19 presents the regression. The variable developmental 
regression accounts for 31.9% of the variance in the overall model while the variable 
impaired social interaction accounts for 29.2% of the variance in the overall model. The 
variable stereotypical/unusual behaviors accounts for 19.6%  and physical sensitivity 
accounts for 6.1% of the overall variance in the regression model. 
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Table 19
Regression Predicting Current Level of Adaptive Functioning and Child Risk 
Characteristics
R         R2        Adjusted      F df P
                        R2
Level of Adaptive Functioning (SIB-R) 
  Predictors
   Block 2: Child Char. .391 .153 .122 4.926  4,109           .001         
Note: Child Char. = Child Characteristics (Physical Sensitivity, Impaired Social Interaction, Developmental Regression, 
Stereotypical/unusual behaviors).
Parent and Child Risk Characteristics
A statistically significant relationship was found between current level of adaptive 
functioning and all the predictor variables related to child and parent risk characteristics 
(block 3), yielding an overall R of .456, F (7,100) = 3.740, p < .01. The presence of both 
child and parent risk characteristics within a participant’s history accounted for a 
significant amount of variance in the current severity/level of adaptive functioning for 
those with ASD. The R2 value for the model is .207. The independent variables in the 
regression collectively account for 20.7% of the variance in the dependent variable. Table 
20 summarizes the regression. Examination of the zero-order correlations indicated each 
of the following variables attributed significantly to the overall variance of the model: 
Impaired Social Interaction = 30.7%, Developmental Regression = 35.2%, and 
Stereotypical/Unusual Behaviors = 22.6%. 
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Table 20
Regression Predicting Current Level of Adaptive Functioning and the Presence of Both 
Parent and Child Risk Characteristics
R         R2        Adjusted      F df P
                        R2
Level of Adaptive Functioning (SIB-R) 
  Predictors
   Block 3: Parent/Child Char. .456 .207 .152 3.740  7,100 .001         
Note: Parent/ Child Char. = Parent and Child Characteristics (Psychological and/or Learning Problems, Length of Gestation, Illness 
during Pregnancy, Physical Sensitivity, Impaired Social Interaction, Developmental Regression, Stereotypical/unusual behaviors).
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CHAPTER V
DISCUSSION
Several factors provided the impetus for this research, predominantly the notable increase 
in the prevalence of ASD over the past decade and a lack of a definitive and unified 
theory regarding the etiology. Secondly, of interest was the wide variation and severity of 
symptoms endured by each individual diagnosed with an autism spectrum disorder. 
Current sources estimate the frequency of ASD to be from 10 to 60 per 10,000 (Baird, 
Charman, Baron-Cohen et al., 2000; Bertrand, Mars, Boyle et al., 2001; Chakarabarti & 
Fombonne, 2001; Horton, 2004; Medical Research Council, 2001 as cited in Purssell, 
2004; Yeargin-Allsopp, 2003). Autism spectrum disorders (autism, Asperger’s and PDD) 
impact a wide range of adaptive attributes. All these disorders are characterized by 
varying degrees of impairment in communication skills, social interactions, and 
restricted, repetitive and stereotyped patterns of behavior. The onset of autism is typically 
noted during the second year of life when significant developmental milestones such as 
speech and socialization become more evident. Although the precise cause of ASD is 
unknown it is probable that it is not the result of a single etiological factor. It is a 
syndrome that appears to have multiple etiologies and is likely due to underlying genetic 
factors and the interaction of these factors with the environment. The likelihood of a 
multifactor cause in the onset of ASD is a common theme throughout the literature. The 
theory that a combination of genetic and environmental factors playing a role in the 
etiology of ASD is both distressing and reassuring. While additional research is needed to 
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determine specific contributing factors, it indicates that the presence of a genetic 
vulnerability alone is not enough to cause ASD. It could therefore be rationalized that 
adequate health and a safe pre and postnatal environment could assist in decreasing the 
chance of ASD occurring in some instances. 
Research related to the etiology of ASD has been inconsistent and controversial.  
A small portion of the increase can likely be attributed to better identification by 
clinicians and more definitive diagnostic criteria. A genetic component has been well 
established with the publication of family and twin studies, however as noted by Wassink 
et al. (2005) no gene has been conclusively identified. While these studies have clearly 
demonstrated that genetics play a role in the etiology of ASD they do not account for the 
increased prevalence. Research has established that ASD has a genetic base, however, 
exposure to particular stimuli during pre and post natal periods of development have also 
been suspected in attributing to the cause and differences in severity among individuals. 
While the symptoms associated with ASD often occur with varied intensity it is not 
completely understood which factors attribute to these variations among individuals.
This study specifically investigated whether multi-valent and thimerosal-
containing childhood vaccinations (particularly MMR) as well as the child’s state of 
health at the time of immunization were related to the onset of ASD. No primary link 
between immunization and the onset of autism was found, however, it is hypothesized
that genetic and nongenetic factors may establish a predisposition whereby adverse 
effects of vaccines occur only in some children. It was also investigated whether parent 
risk characteristics (a family history positive for psychological and learning disorders, 
length of gestational period, and maternal illness during pregnancy) as well as the 
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presence of child risk characteristics (e.g., physical sensitivity, impaired social 
interaction, developmental regression and stereotypical/unusual behaviors) to a marked 
degree during the first five years of life predict an individuals current levels of autism 
symptomology and adaptive functioning.
Vaccination programs are under particular scrutiny due to reports by parents 
whose children began to demonstrate autistic behaviors shortly after being immunized. 
There were initial reports both in the United States and in the United Kingdom that the 
introduction of the poly/multi-valent MMR vaccine coincided with the apparent increase 
in cases of autism spectrum disorders. However, the majority of researchers have found 
no convincing evidence to suggest that MMR vaccination increases the risk of autism 
spectrum disorders. In fact, despite the mounting research efforts, it appears that little is 
still clearly known about the causation of autism which could explain the reason for 
suggesting MMR as a possible cause. The current study explored the suggestion that 
MMR vaccination could act as a possible catalyst for the onset of autism and found 
neither that MMR, nor any other childhood vaccination was associated with the onset of 
an autism spectrum disorder. The findings of no increased risk for the onset of autism for 
individuals who are administered the MMR vaccine was consistent with several previous 
studies that showed no temporal relationship between MMR vaccination and the 
onset/development of autistic symptoms (Dales et al., 2001; Honda et al., 2005; Stehr-
Green et al., 2003; Taylor et al., 1999). Children receive their first MMR vaccination 
during their second year of life, the age autism generally manifests itself, chance alone 
dictates that some cases will appear shortly after vaccination. The significant amount of 
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inconsistency among the research related to MMR and ASD indicates the additional 
research is required before thimerosal is vindicated.
While it is impossible to mention all potential variables, it is of particular interest 
that over the past decade there has been in increase in autism and autoimmune disorders.  
As Semple (2004) noted, there has been an increase in immune dysfunction and 
autoimmune disorders over the past 25 years and that these disorders have been tied to 
environmental causes. A cumulative effect for environmental exposures is certainly a 
strong possibility, particularly if autism were found to be a disorder of immune 
dysfunction. The condition of an individual’s immune system when immunized and the 
relationship to the onset of autism has also been investigated by Singh (1998, 2000). 
While the majority of the studies have not proved a solid link, they certainly provide 
sufficient circumstantial evidence which should not be ignored. It is likely that our 
knowledge of the immune system is not yet fully understood. In the current study no 
association was found between the participant’s state of health at the time of vaccination 
and the onset of an autism spectrum disorder. These findings are consistent with the 
majority of the current literature. Perhaps the lack of statistically significant findings
suggest that genetic factors are more significant in predicting the onset of ASD than 
originally thought.
While there is not much one can do to prevent perinatal trauma, greater control 
can be exerted to ensure adequate pre-and postnatal environments. Although children 
who endure pre- and postnatal difficulties have a greater chance of surviving than they 
did in previous decades, they are at greater risk of suffering from life long
neurodevelopmental difficulties such as autism. Findings related to pre-, peri- and 
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postnatal factors should be considered in conjunction with increased prevalence and 
severity of ASD. Although the results of this study could not definitively determine 
causality, findings do suggest that some factors related to parent risk characteristics and 
child risk characteristics present to a marked degree prior to the age of five have a greater 
impact on predicting the level of ASD symptomology and level of adaptive functioning
than generally expected. 
Despite the lack of significant findings for the dependent variable related to onset 
of autism, variables were found to predict the current level of autism symptomology and 
level of adaptive functioning. It was not a significant surprise that the variables related to 
child risk characteristics within the first five years of life were found to have a significant 
effect on current level of symptomology and level of adaptive functioning. The variables 
that comprised these models are highly associated with diagnostic criteria of ASD. These 
significant findings also indicate validity and reliability of the rating scale used in the 
study. Because the independent variables are closely related to diagnostic criteria for 
ASD and were found to be significant predictors of ASD symptomology it indicated that 
the GARS adequately measured information it was designed to assess. The variables 
related to parent risk characteristics were also found to be predictors of current levels of 
ASD symptomology but not with current levels of adaptive functioning . This was not 
surprising as the literature has shown strong genetic associations with family and twin 
studies. Gillberg and Cederlund (2005) found that approximately 50% of all boys with 
Asperger’s have a paternal family history of autism spectrum disorder and that one in 
four individuals with Asperger’s experienced pre- and perinatal risk factors.  As the 
disorders that comprised the parent risk characteristics (anxiety, depression, speech-
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language disorder, learning disorder) are thought to have a genetic basis it seems logical 
that the presence of psychological disorders within one’s family history could potentially 
exacerbate an individual’s level of ASD symptomology. The presence of both parent and 
child risk characteristics were also found to be significant predictors of current ASD 
symptomlogy and adaptive functioning. These significant findings also indicate validity 
and reliability of the rating scales used in the study. Because the independent variables 
are closely related to diagnostic criteria for ASD as well as adaptive behavioral skills and 
were found to be significant predictors of ASD symptomology and adaptive functioning 
it indicated that the GARS and SIB-R adequately measured information they were 
designed to assess. Moreover, findings of the current study would suggest that early 
presence of ASD symptomology predicts that these symptoms/characteristics will be 
pervasive and stable across time. The parent risk characteristic related to length of 
gestational period was shown to have an inverse relationship with the severity of ASD.
The correlation indicated a longer gestational period was associated with less ASD 
symptomology. Although this variable was found to be statistically significant it may not 
be of clinical significance in that shortened gestational periods are more commonly 
associated with a risk of neurodevelopmental and medical difficulties. The parent 
characteristic variable of illness during pregnancy as well as other factors such as 
exposure to teratogens in utero have been shown to be associated with various 
psychological and medical disorders in children (Cox et al., 1989; Geier & Geier, 2003; 
Marsh et al., 1987; Redwood et al., 2001; Verdoux, 2004).
The examination of pre-, peri-, and postnatal factors and their ability to predict 
current levels symptom severity and adaptive functioning was not readily found in the 
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literature. The current study appears to be one of a few to date to investigate factors 
associated with severity of ASD symptoms and has brought attention to environmental 
factors more commonly examined in relation to the onset of ASD rather than severity of 
the disorder.
Limitations
A few limitations have been noted for this study. The sample size was limited and 
only contained 114 participants. The size and power of this sample may not have been 
sufficient to explain the associations found. The sample was more heterogeneous, 
including individuals with autism, Asperger’s and/or PDD.  However, it has been noted 
by Szatmari (1999) that autism is likely to be etiologically heterogeneous. In addition, a 
control/comparison group was not included. Data were obtained from parent report and 
no children were individually examined. Although no verification of diagnosis was 
conducted, most respondents, although not specifically requested, sent copies of their 
child’s diagnostic evaluation/report. The majority of requested data was obtained from 
retrospective parental reports. While the validity of these accounts, particularly where 
precise dating was requested could be questioned, most participants within the sample 
were still fairly young when data was collected and the respondents inaccurate recall of 
information should have been kept to a minimum.
Implications for the Future
Although the debate is ongoing as to whether autism has a genetic or 
environmental cause or both, most would agree that the prevalence has increased. The 
question is whether the observed increase is due to better diagnosis of autism spectrum 
disorders or other factors such as thimerosal-containing vaccinations. If MMR were a 
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significant cause of autism, it would be expected that a cluster of cases would have been 
seen promptly after the introduction of the poly/multi-valent MMR vaccine, but such a 
cluster has yet to be evidenced among the many researchers who have examined the data.  
Additional concern that poly/multi-valent vaccinations might result in immunosupression 
is also unwarranted as Miller et al (2003) noted, there is no increase in invasive bacterial 
infections in children immediately after MMR vaccination…therefore it would indicated 
that a polyvalent immunization such as MMR would not have an adverse effect on an 
individuals’ immune system. 
There is a natural tendency for all of us to seek out explanations for occurrences 
that are uncertain, painful, and unexplained, such as the onset of autistic symptoms in a 
young child. Perhaps this is even more so for parents of children who suddenly 
experience a regression or complete loss of previously learned skills. Parents base their 
beliefs on their own experiences, observations, and the temporal association between 
vaccination and the onset of symptoms. Concerns regarding the development of autistic 
characteristics or atypical developmental patterns typically occur before 24 months and 
usually during the second year (De Giacomo & Fombonne, 1998; Rogers & DiLalla, 
1990; Short & Schopler, 1988; Volkmar et al, 1985). When one considers that children 
receive a high number of vaccinations, including the MMR vaccine, during the second 
year of their life, when autism typically manifests itself; chance alone would determine 
that some cases will appear shortly after immunization has occurred. Although the initial 
symptoms of autism are typically discernible at the age one receives the MMR 
vaccination, there is not sufficient epidemiological evidence that immunizations cause 
autism. Determining the onset of autism is difficult even under ideal circumstances.  
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Despite negative findings related to thimerosal and the fact that it is recognized by 
some as a health hazard, many nations continue to add it to their vaccines. Vaccination 
has been and will continue to be a necessity that helps control the outbreak of deadly 
diseases. Vaccines are intended to protect both the individual and society. Those in the 
United States who are adversely affected by the MMR or any vaccination should report 
their experiences and adverse reactions to the Vaccine Adverse Events Reporting System 
(VAERS) database so that information can continue to be generated in relation to the 
safety or lack of safety related to vaccines.
In the 1970’s immunization concerns were of lower priority and case-based 
information was minimal. Coordinators were non-existent and vaccination rates appeared 
to slump because of the lack of assigned responsibility. The pertussis experience should 
not be repeated with current vaccinations, particularly MMR. While no vaccination can 
come without risk, the risk must be weighed against the advantages of protection against 
debilitating diseases. Concerns exist among parents and will likely continue to grow and 
spread. Most would agree that there is certainly a need for greater understanding of 
vaccine contraindications and precautions before a specific risk intervention can be 
developed. Those with the task of advising patients and families have the responsibility to 
make sure that their decisions can be based on hard scientific evidence. Keeping an open 
mind about causation and continuing to explore new hypotheses is important, but a task 
of higher importance is for professionals to remain skeptical about claims of association 
that might fall short of strict scientific criteria. 
Irrespective of conclusions from various organizations and researchers that there 
is no relationship between the thimerosal-containing MMR vaccine and autism, and their 
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belief that no further studies are necessary to evaluate the relationship, it is evident from 
the conflicting pool of data from recent years that additional research should be carried 
out and should focus on thimerosal-containing/mercury- associated exposure. For research 
to be successful in this domain, researchers from clinical and epidemiological fields will 
need to make concerted efforts to combine their scientific strategies. Collaboration 
among these fields is necessary as there appears to be a multi-factor etiology to ASD. 
With out collaborative efforts it will be difficult to determine which combination of 
genetic and environmental factors may be contributing to the onset and severity of ASD.
Findings have strongly supported the hypothesis that the perinatal period is a 
crucial neurodevelopmental stage in which exposure to deleterious environmental events 
may increase vulnerability (Verdoux, 2004). Although a link has been shown between 
some variables and the severity of ASD it appears to be weak and possibly nonspecific, 
with these factors more likely being consequences of the disorder. The literature is sparse 
in studies investigating factors impacting the severity of ASD among individuals. As 
well, the operational definitions of severity are widely varied and the methodologies lack 
the use of standardized instruments and measurable outcomes. Although the few 
investigations that exist have not been fruitful in identifying a means of preventing ASD 
or lessening the severity of the disorder it is still appropriate to continue examining pre 
and postnatal factors. The current study contributed to the literature by providing clearly 
defined and measurable variables related to severity, which could be replicated for future 
research. Identification of these risk factors could be useful for early detection and 
intervention planning while ultimately alleviating the potential severity of the disorder 
over ones lifetime.
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There is no disputing that this disorder has taken a toll on the families of affected 
children, the children themselves, and the school districts and agencies serving them. 
Higher functioning children with ASD report feelings of anger, depression, and 
frustration from trying to communicate and function socially in a world that requires 
these skills to survive (Semple, 2004). Because the research is inconclusive, parents are 
often victims of proposed cures that are nothing more than empty promises. The public 
schools and state agencies are up against the rising cost of caring for the growing number 
of individuals afflicted with ASD. Current and promising treatments often include costly 
intensive one on one therapy for the areas of speech and language, behavior, 
socialization, and fine and gross motor skills. Continued research into the etiology  of 
ASD could potentially lead to earlier detection, effective early intervention, prevention 
and the hopes of someday finding a cure.
Despite the growing amount of literature to date, it appears we still know far too 
little about ASD for anyone to make a final or definitive conclusion regarding the 
etiology and severity. Autism has been bewildering researchers and clinicians for several 
decades. This complex disorder includes a broad variety of symptoms which typically 
manifest before the age of three. Nothing will likely simplify the search for ASD causes 
but every possible risk factor that is identified alleviates some of the mystery associated 
with the search. Continued research from all disciplines could help alleviate the life long 
devastation associated with this disorder. Consistent and appropriate designs and methods 
with clearly defined and measurable variables are critical to achieving meaningful and 
applicable results. Although biological and environmental risk will never be completely 
eradicated, it is not unreasonable to strive for prevention and reduce the occurrence of 
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adverse outcomes. For that reason, prevention of avoidable pre-, peri-, and postnatal risks 
should be of highest priority.
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APPENDICES
Appendix A: Cover Letter
AUTISM STUDY Spring/Summer 2005 Investigator: Jennifer Aldridge-Sumner, M.Ed.
Autism is a pervasive developmental disorder due to the fact that it impacts a wide range of areas in an 
individual’s life (e.g., language, communication, social interactions, cognitive functioning, and behavior).  
The prevalence of Autism is estimated to affect 6 individuals per 1000.  The purpose of the research study 
is to investigate whether the effects of childhood immunizations on the onset of Autism Spectrum 
Disorders as well as additional medical history that might affect the severity of Autism Spectrum 
Disorders.  This study is my dissertation and the final component to completing my doctoral degree in 
school psychology at Oklahoma State University.  Your participation would be greatly appreciated. 
Participants will be asked to complete a brief and detailed developmental history form along with an 
adaptive behavior rating scale and/or Autism rating scale (if one has not been recently completed).  The 
developmental history form will inquire about demographics, pregnancy, birth, developmental milestones, 
immunizations, diagnosis and other pertinent medical information.  Information not readily available from 
the participant that may need to be obtained from school records will be sought through the signing of a 
medical release form/consent form. Permission to access school records will be for the purpose of obtaining 
only information pertaining to the student’s immunization history and psycho-educational testing (e.g., to 
obtain a score if the Autism rating scale has recently been completed).
Your participation is completely voluntary and there is no penalty for not choosing to participate.  Your 
participation will be kept completely confidential as your information will only be identified through 
codes/numbers.  Your participation in the study may help researchers and other professionals who work 
with children understand factors related to the etiology of Autism Spectrum Disorders.
If you are willing to participate in the study or if you have any questions please e-mail me at 
Jifsumner@aol.com or call 918-749-1840 (Tulsa).  Packets will be sent to you through the mail with a self-
addressed/stamped envelope for their return.
Sincerely,
Jennifer Aldridge-Sumner, M.Ed.
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Appendix B: Informed Consent Form
Consent Form
Spring/Summer 2005 Study:  An Investigation of the Effects of Childhood Immunizations on the    
Onset of Autism and Risk Factors that Predict Current Levels
of Autistic Symptomology and Adaptive Functioning
I, , hereby authorize or direct Jennifer Aldridge-
Sumner and/or Dr. Terry Stinnett to perform the following procedure:
Present to me a developmental health history form an Autism rating scale (Gilliam Autism Rating Scale or 
Asperger’s Syndrome Diagnostic Scale) and an Adaptive Behavior Scale.
Details of the Study:
Participants will be parents of children (ages 3to 29) who have been diagnosed with an Autism Spectrum Disorder and identified 
through various autism support groups across the United States. Participants will be asked to volunteer and those who choose to 
participate will be asked to sign an informed consent form.  There is no risk to the participants and confidentiality will be maintained.  
Demographic information along with detailed developmental, medical, diagnostic, and immunization history will be requested through 
questionnaire format. Information not readily available from the participant that may need to be obtained from school records will be 
sought through the signing of a medical release form.  Participants will be guaranteed privacy and anonymity regarding the 
information relayed for the purpose of the proposed study.  
I understand that participation is completely voluntary, there is no penalty for not choosing to participate, that I may 
withdraw from the study at any time with no negative consequences to me or my child and that participation and 
responses will be kept completely confidential. There is minimal risk or possible discomfort associated with 
participation.  I understand this study may help researchers and other professionals who work with children understand 
factors related to the etiology of Autism Spectrum Disorders.
As part of this study, I understand that by signing this consent form I give permission for the examiners to access my 
child’s school records to obtain only information pertaining to his/her immunization history and psycho-educational 
testing.  Access to his/her file is only necessary if I am unable to provide the above listed information (i.e., 
immunization records, psycho-educational evaluation, and a current/recently completed Gilliam Autism Rating Scale) 
to the examiner at this time.
I may contact Dr. Terry Stinnett at Oklahoma State University at (405) 744-9456 or Jennifer Aldridge-Sumner at (918) 
749-1840.  I may also contact Dr. Sue Jacobs, IRB Chair, 415 Whitehurst, Oklahoma State University, Stillwater, OK 
74078: (405) 744-1676.
I have read and fully understand the consent form.  I sign freely and voluntarily.  A copy has been given to me.
Date:
Time:  (a.m./p.m.)
Signed:
I certify that I have personally explained all of the elements of this form to the participant before requesting him or her 
to sign it.
Signed:
Project Director or Authorized Representative     
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Appendix C: Developmental and Medical History Form
#_____________
Developmental and Medical
 History Form
123
FAMILY AND SOCIAL HISTORY
Child’s Information:
Gender:    M     F        Birth Date:  ___________       Current Age:  __________
Race:  (circle one)  African American,  Caucasian,  American Indian,  Hispanic,  Asian,  Other __________
Education:  
Highest Grade Completed (1-12)  _________ High School Graduate / GED (circle one)
Highest Degree Awarded: (circle one)   High School      Bachelors      Masters       Doctorate  
Diagnosis:(circle one)    Autism Disorder        Asperger’s Disorder           Pervasive Developmental 
Disorder
Age at initial diagnosis:________________
Parents Information:
Mother: (circle one)  Biological,  Adoptive,  Step,  Foster, Legal Guardian
Age:  ________
Race:  (circle one)  African American,  Caucasian,  American Indian,  Hispanic,  Asian,  Other __________
Education:  
Highest Grade Completed (1-12)  _________ High School Graduate / GED (circle one)
Highest Degree Awarded: (circle one)   High School     Bachelors      Masters     Doctorate 
Father:  (circle one)  Biological,  Adoptive,  Step,  Foster,  Legal Guardian
Age:  ________
Race:  (circle one)  African American,  Caucasian,  American Indian,  Hispanic,  Asian,  Other __________
Education:  
Highest Grade Completed (1-12)  _________ High School Graduate / GED (circle one)
Highest Degree Awarded: (circle one)   High School     Bachelors      Masters     Doctorate
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Additional Children in the Family:
Gender      Age Relation              Medical or Psychological Problems?
(biological, step, foster, adoptive)
M / F    B       S F A
M / F    B S  F A
M / F    B S F A
M / F    B S F A
M / F    B S F A
M / F    B S F A
Is there any history of the following? 
(Use the following: M=mother, F=father, S=sister, B=brother, GM=grandmother, GF=grandfather, U=uncle, A=aunt, 
C=cousin)
Biological Mother’s Side of the Family Biological Father’s Side of the Family
_____Learning Problems _____Learning Problems
_____Speech/Language Problems _____Speech/Language Problems
_____Mental Retardation _____Mental Retardation
_____Seizures/Epilepsy _____Seizure/Epilepsy
_____Attention/Concentration Problems _____Attention/Concentration Problems
_____Hyperactivity _____Hyperactivity
_____Anxiety _____Anxiety
_____Obsessive-Compulsive Disorder _____Obsessive Compulsive Disorder
_____Unreasonable Fears (i.e., phobias) _____Unreasonable Fears (i.e., phobias)
_____Depression _____Depression
_____Alcoholism/Drug Abuse _____Alcoholism/Drug Abuse
_____Autism Spectrum Disorder _____Autism Spectrum Disorder
_____Psychiatric Hospitalization _____Psychiatric Hospitalization
_____Other Psychiatric Disorder _____Other Psychiatric Disorder
_____Other__________________________ _____Other______________________________
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PREGNANCY AND BIRTH HISTORY
1. How many weeks did pregnancy last (normal 38-42 weeks) __________
2. Was any medication used during pregnancy (circle one)       Yes               No
If yes, please list medications taken during pregnancy (include vitamins, all prescription drugs and 
over the counter drugs)
Medication Months Taken (of 9) Dose Reason for Taking
3. Was alcohol consumed during pregnancy? YES NO
4. Was smoking or tobacco used during pregnancy? YES NO
5. Were any other drugs (not prescribed) used during pregnancy? YES NO
6. Were there any illnesses during pregnancy? YES NO
If YES, please describe
_____________________________________________________________________________
7. Were there any traumas during pregnancy? YES NO
If YES, please describe
______________________________________________________________________________
8. Was there any exposure to chemicals, toxic substances or people YES NO
with infections during the pregnancy?  
If YES, please describe
_______________________________________________________________________________
Child’s birth weight:  _____pounds  ______ounces
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DEVELOPMENTAL PROGRESSION
At what age did you become concerned about your child’s development? ___________
At what age was your child diagnosed? Diagnosis (circle one):   Autism     or     Asperger’s
Developmental Milestones: (List age in months for each milestone achieved –average is listed in 
parenthesis)
Slower Average Faster
Rolled Over (2-5 months) ___________________________________
Sat Alone (5-8 months) ___________________________________
Crawled (7-8 months) ___________________________________
Walked alone (11-14 months) ___________________________________
First words (9-13 months) ___________________________________
Put words together/Sentences (15-18 months) ___________________________________
Toilet Trained (24-36 months) ___________________________________
Rode a tricycle (21-36 months) ___________________________________
Dressed self independently (36-42 months) ___________________________________
Were any of the following present to an unusual degree during the first five years of life?
Y N High Fevers
Y N Pneumonia
Y N Meningitis
Y N Poisoning/Toxic Exposure
Y N Colic
Y N Poor Weight Gain
Y N Disrupted Sleep
Y N Difficult to Calm/Pacify
Y N Did not Like to be Held
Y N Irritability/Easily Agitated
Y N Clumsy/Uncoordinated
Y N Difficulty Making Eye Contact
Y N Staring at or Avoiding Looking at Others
Y N Rocking, Spinning, or Head Banging
Y N Walking on Tiptoes or Flapping Hands
Y N Unusual Play Behaviors
Y N Difficulty Interacting/Playing with Others
Y N Slow to Roll, Crawl, or Walk
Y N Slow to use Words or Sentences
Y N Loss of Abilities/Regression
Y N Sensitivity to Sounds/Sights/Touch/Taste
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IMMUNIZATION/VACCINATION HISTORY
Please provide the following information regarding your child’s immunization history (the typical 
immunization schedule followed in the United States is in parenthesis)
Immunization         Sick or Healthy at time      Adverse Reactions?
                           of Immunization
Diptheria/Tetanus/Pertusis
2 months S H Illness   /   Loss of skills
4 months S H Illness   /   Loss of skills 
6 months S H Illness   /   Loss of skills
12-15 months S H Illness   /   Loss of skills
& 4-6 years S H Illness   /   Loss of skills
Hepatitis B
2 months S H Illness   /    Loss of skills
4 months S H Illness   /    Loss of skills
& 12-15 months S H Illness   /    Loss of skills
Polio
2 months S H Illness   /    Loss of skills
4 months S H Illness   /    Loss of skills
12-15 months S H Illness   /    Loss of skills
& 4-6 years S H Illness   /    Loss of skills
Influenza
2 months S H Illness   /    Loss of skills
4 months S H Illness   /    Loss of skills
& 6 months S H Illness   /    Loss of skills
Measles/Mump/Rubella
12-15 months S H Illness   /    Loss of skills
& 4-6 years S H Illness   /    Loss of skills
Vericella
(12-15 months) S H Illness   /    Loss of skills
______________________________________________________________________________________
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EVALUATION
Please refer to your child’s most recent psycho-educational evaluation to complete the following section. 
Please see the examiner for help with this section if necessary.
Which test was used to assess your child’s intellectual functioning?  What scores were obtained?
Date Administered?
a.  WISC-III: PIQ=______ VIQ=______ FSIQ=______
b.  WISC-IV: VCI=______ PRI=_______ WMI=______ PSI=______ FSIQ=______
c.   DAS:       Verbal=_____      Nonverbal Reasoning=______    Spatial=_____      General Cognitive Ability=______
d.  Leiter/Leiter-R:    Full IQ=_______         Brief IQ=_______
e. TONI-3: TONI-3 Quotient=_________
f.  Other: ___________________________________________________
If you have completed one of the following adaptive behavior rating scales within the last year please report the 
following scores. If it has been more than one year or you have not completed one of the following rating scales listed 
below, please see the examiner at this time.
Date Administered?_______________   
a. Scales of Independent Behavior-Revised (SIB-R): Broad Independence=___________
Subtest standard scores:      Motor Skills ____     Social Interaction/Communication Skills_____   
Personal Living Skills_____   Community Living Skills_____
b.  Vineland Adaptive Scales (Vineland): Adaptive Behavior Composite=_____________
Subtest standard scores:     Communication____   Daily Living Skills _____   Socialization _____     
Motor Skills _____
If you have completed one of the following autism rating scales within the last year please report the following scores. 
If it has been more than one year or you have not completed one of the following rating scales listed below, please see 
the examiner at this time.
Date Administered?_______________
a.   Gilliam Autism Rating Scale (GARS):      Autism Quotient=________  Probability of Autism=__________
Subtest standard scores:   Stereotyped Behaviors_____   Communication _____   Social Interaction ______
b.   Gilliam Asperger’s Disorder Scale (GADS): Asperger’s Disorder Quotient=______
Probability of Asperger’s=______
Subtest standard scores:   Social Interaction ____ Restricted Patterns of Behavior ____  Cognitive Patterns_____
Pragmatic Skills _____      
c.  Asperger’s Syndrome Diagnostic Scale (ASDS):   Asperger’s Syndrome Quotient=_____  
Probability of Asperger’s=_____
Subtest standard scores: Language ____ Social _____ Maladaptive _____  Cognitive ____  Sensorimotor ____
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